Experimental Liver Cirrhosis - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:	Experimental Liver Cirrhosis	go back to main search page
Accession:	DOID:9001573	browse the term
Definition:	Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
Synonyms:	exact_synonym:	Experimental Hepatic Cirrhosis; Experimental Hepatic Fibrosis; Experimental Liver Cirrhoses
	primary_id:	MESH:D008106
	alt_id:	RDO:0006022

show annotations for term's descendants Sort by:
Rat (913) Mouse (921) Human (911) Chinchilla (817) Bonobo (881) Dog (876) Squirrel (826) Pig (880) Green Monkey (871) Naked Mole-rat (828) All
Genes (911)

Experimental Liver Cirrhosis

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

CTD Direct Evidence: marker/mechanism

NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229

G

arylacetamide deacetylase

CTD Direct Evidence: marker/mechanism

NCBI chr 3:151,814,116...151,828,488
Ensembl chr 3:151,814,073...151,828,488

G

aminoadipate aminotransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699

G

4-aminobutyrate aminotransferase

CTD Direct Evidence: marker/mechanism

NCBI chr16:8,674,617...8,784,570
Ensembl chr16:8,674,596...8,784,575

G

ATP binding cassette subfamily B member 1

CTD Direct Evidence: marker/mechanism

PMID:16182555 PMID:17072980

NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323

G

ATP binding cassette subfamily C member 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594

G

ATP binding cassette subfamily C member 5

CTD Direct Evidence: marker/mechanism

NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939

G

ATP binding cassette subfamily G member 1

CTD Direct Evidence: marker/mechanism

NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,304,389

G

ATP binding cassette subfamily G member 5

CTD Direct Evidence: marker/mechanism

NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865

G

ATP binding cassette subfamily G member 8

CTD Direct Evidence: marker/mechanism

NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988

G

actin binding LIM protein family member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 5:149,141,493...149,260,542
Ensembl chr 5:149,141,483...149,260,542

G

acetyl-CoA acetyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:108,116,705...108,147,603
Ensembl chr11:108,116,695...108,148,957

G

acyl-CoA binding domain containing 4

CTD Direct Evidence: marker/mechanism

NCBI chr17:45,131,597...45,144,176
Ensembl chr17:45,132,600...45,144,181

G

angiotensin I converting enzyme

severity

mRNA: increased expression:liver (rat)
mRNA:increased expression:liver (rat)
protein:increased activity:plasma (human)

RGD

PMID:19424597 PMID:24035938 PMID:23663763 PMID:8445218

RGD:25671449, RGD:21408579, RGD:25671457, RGD:25671458

NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380

G

angiotensin converting enzyme 2

protein:increased expression:liver
mRNA, protein:increased expression, increased activity:liver (rat)

RGD

PMID:19793108 PMID:16166274

RGD:2316776, RGD:40818265

NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236

G

acetylcholinesterase (Yt blood group)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974

G

atypical chemokine receptor 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354

G

acyl-CoA thioesterase 9

CTD Direct Evidence: marker/mechanism

NCBI chr X:23,701,055...23,743,276
Ensembl chr X:23,701,055...23,766,475

G

acyl-CoA oxidase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283

G

acid phosphatase 5, tartrate resistant

CTD Direct Evidence: marker/mechanism

NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993

G

acyl-CoA synthetase long chain family member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818

G

actin alpha 2, smooth muscle

CTD Direct Evidence: marker/mechanism
associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)

CTD
RGD

PMID:26435214 PMID:26739621 PMID:29323718

NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339

G

actinin alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,123...68,979,440

G

activin A receptor type 2A

mRNA:decreased expression:liver

RGD

NCBI chr 2:147,844,517...147,930,822
Ensembl chr 2:147,844,517...147,930,826

G

adenosine deaminase

CTD Direct Evidence: marker/mechanism

NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252

G

ADAM metallopeptidase domain 17

CTD Direct Evidence: marker/mechanism

NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732

G

adducin 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565

G

adhesion G protein-coupled receptor E1

CTD Direct Evidence: marker/mechanism

NCBI chr19:6,887,579...6,940,450
Ensembl chr19:6,887,566...6,940,459

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746

G

alcohol dehydrogenase 4 (class II), pi polypeptide

CTD Direct Evidence: marker/mechanism

NCBI chr 4:99,123,658...99,144,297
Ensembl chr 4:99,123,657...99,157,792

G

alcohol dehydrogenase iron containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:66,432,504...66,468,907
Ensembl chr 8:66,432,492...66,468,907

G

adiponectin, C1Q and collagen domain containing

CTD Direct Evidence: therapeutic

NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463

G

adiponectin receptor 2

severity

RGD

NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674

G

adrenomedullin

protein:increased expression:plasma
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15370692 PMID:16610064 PMID:16713642

NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397

G

adenosine A2a receptor

CTD Direct Evidence: marker/mechanism

NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357

G

adenosine A3 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 1:111,499,429...111,503,633
Ensembl chr 1:111,499,429...111,503,633

G

adrenoceptor alpha 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 5:159,865,086...159,989,205
Ensembl chr 5:159,865,080...159,973,012

G

adrenoceptor beta 1

mRNA, protein:increased expression:liver

RGD

NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904

G

adrenoceptor beta 2

mRNA, protein:increased expression:liver

RGD

NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623

G

adrenoceptor beta 3

mRNA, protein:increased expression:liver

RGD

NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599

G

apoptosis enhancing nuclease

CTD Direct Evidence: marker/mechanism

NCBI chr15:88,604,683...88,632,281
Ensembl chr15:88,621,337...88,632,281

G

afamin

CTD Direct Evidence: marker/mechanism

NCBI chr 4:73,481,745...73,504,001
Ensembl chr 4:73,481,745...73,504,001

G

alpha fetoprotein

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17072980 PMID:30346985

NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174

G

advanced glycosylation end-product specific receptor

treatment

RGD

NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322

G

ArfGAP with FG repeats 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:227,472,156...227,561,217
Ensembl chr 2:227,472,152...227,561,217

G

amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 1:99,849,258...99,924,023
Ensembl chr 1:99,850,361...99,924,023

G

angiotensinogen

CTD Direct Evidence: marker/mechanism

NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576

G

angiotensin II receptor type 1

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12890498 PMID:25380136 PMID:24619965

NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008

G

AHNAK nucleoprotein

CTD Direct Evidence: marker/mechanism

NCBI chr11:62,433,544...62,546,806
Ensembl chr11:62,433,542...62,556,235

G

axin interactor, dorsalization associated

CTD Direct Evidence: marker/mechanism

NCBI chr 1:222,668,013...222,712,491
Ensembl chr 1:222,668,013...222,713,210

G

allograft inflammatory factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021

G

aldo-keto reductase family 1 member B

CTD Direct Evidence: marker/mechanism

NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284

G

aldo-keto reductase family 1 member C1

CTD Direct Evidence: marker/mechanism

NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283

G

aldo-keto reductase family 1 member C3

CTD Direct Evidence: marker/mechanism

NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686

G

AKT serine/threonine kinase 1

protein:increased phosphorylation:liver

RGD

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759

G

AKT interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr16:53,491,040...53,504,412
Ensembl chr16:53,491,040...53,504,411

G

albumin

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16642209 PMID:17963606 PMID:21163135 PMID:30346985

NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482

G

aldehyde dehydrogenase 1 family member A1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442

G

aldehyde dehydrogenase 1 family member B1

CTD Direct Evidence: marker/mechanism

PMID:15650968 PMID:25380136

NCBI chr 9:38,392,702...38,398,661
Ensembl chr 9:38,392,702...38,398,661

G

aldehyde dehydrogenase 1 family member L1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:126,103,570...126,197,945
Ensembl chr 3:126,103,562...126,197,994

G

aldehyde dehydrogenase 1 family member L2

CTD Direct Evidence: marker/mechanism

NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643

G

aldehyde dehydrogenase 2 family member

CTD Direct Evidence: marker/mechanism

NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532

G

alpha-methylacyl-CoA racemase

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 5:33,986,165...34,008,050
Ensembl chr 5:33,986,165...34,008,104

G

angiopoietin 1

disease_progression

protein:increased expression:liver

RGD

NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055

G

angiopoietin 2

mRNA, protein:increased expression:multiple organs (rat)

RGD

NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409

G

angiopoietin like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313

G

anoctamin 6

CTD Direct Evidence: marker/mechanism

NCBI chr12:45,216,095...45,440,404
Ensembl chr12:45,215,987...45,482,280

G

acidic nuclear phosphoprotein 32 family member A

treatment

RGD

NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897

G

annexin A1

mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:8755646

NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629

G

annexin A2

CTD Direct Evidence: marker/mechanism

NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883

G

annexin A3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451

G

annexin A4

CTD Direct Evidence: marker/mechanism

NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112

G

annexin A5

CTD Direct Evidence: marker/mechanism

NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995

G

adaptor related protein complex 1 subunit sigma 2

CTD Direct Evidence: marker/mechanism

NCBI chr X:15,825,806...15,854,813
Ensembl chr X:15,825,806...15,854,931

G

adaptor related protein complex 3 subunit sigma 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:115,841,935...115,914,081
Ensembl chr 5:115,841,592...115,914,081

G

apoptotic peptidase activating factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433

G

amyloid beta precursor protein binding family B member 1 interacting protein

CTD Direct Evidence: marker/mechanism

NCBI chr10:26,438,341...26,567,803
Ensembl chr10:26,438,341...26,568,449

G

adipocyte plasma membrane associated protein

CTD Direct Evidence: marker/mechanism

NCBI chr20:24,962,925...24,992,751
Ensembl chr20:24,962,925...24,992,751

G

apolipoprotein A1

RGD

NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622

G

apolipoprotein A4

CTD Direct Evidence: marker/mechanism

NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304

G

apolipoprotein B mRNA editing enzyme catalytic subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:7,649,400...7,670,599
Ensembl chr12:7,649,400...7,665,908

G

apolipoprotein L4

CTD Direct Evidence: marker/mechanism

NCBI chr22:36,189,128...36,204,833
Ensembl chr22:36,189,124...36,204,840

G

apolipoprotein N, pseudogene

CTD Direct Evidence: marker/mechanism

NCBI chr12:56,376,748...56,377,450
Ensembl chr12:56,376,818...56,377,331

G

amyloid beta precursor protein

CTD Direct Evidence: marker/mechanism

NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:57,227,729...57,273,471
Ensembl chr 3:57,227,726...57,278,105

G

aquaporin 7

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 9:33,383,191...33,402,568
Ensembl chr 9:33,383,179...33,402,682

G

arginase 1

mRNA, protein:decreased expression:liver (rat)

RGD

NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332

G

arginase 2

mRNA, protein:increased expression:liver

RGD

NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708

G

Rho GTPase activating protein 30

CTD Direct Evidence: marker/mechanism

NCBI chr 1:161,046,946...161,069,891
Ensembl chr 1:161,046,946...161,069,970

G

Rho GTPase activating protein 9

CTD Direct Evidence: marker/mechanism

NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814

G

Rho GDP dissociation inhibitor beta

CTD Direct Evidence: marker/mechanism

NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728

G

ARF like GTPase 11

CTD Direct Evidence: marker/mechanism

NCBI chr13:49,628,507...49,633,872
Ensembl chr13:49,628,507...49,633,872

G

ARF like GTPase 8A

CTD Direct Evidence: marker/mechanism

NCBI chr 1:202,133,404...202,144,737
Ensembl chr 1:202,133,404...202,144,743

G

armadillo repeat containing X-linked 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:101,550,547...101,554,700
Ensembl chr X:101,550,547...101,554,700

G

actin related protein 2/3 complex subunit 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 7:99,374,259...99,394,816
Ensembl chr 7:99,374,249...99,394,816

G

arrestin beta 2

CTD Direct Evidence: marker/mechanism
protein:increased expression:aorta

CTD
RGD

PMID:25380136 PMID:17256744

NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499

G

N-acylsphingosine amidohydrolase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998

G

asparagine synthetase (glutamine-hydrolyzing)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542

G

asporin

CTD Direct Evidence: marker/mechanism

NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,482,506

G

argininosuccinate synthase 1

mRNA:decreased expression:liver (rat)

RGD

NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274

G

activating transcription factor 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

ATPase phospholipid transporting 10D (putative)

CTD Direct Evidence: marker/mechanism

NCBI chr 4:47,485,275...47,593,486
Ensembl chr 4:47,485,275...47,593,486

G

ATPase H+ transporting V1 subunit D

CTD Direct Evidence: marker/mechanism

NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265

G

attractin

CTD Direct Evidence: marker/mechanism

NCBI chr20:3,471,018...3,651,118
Ensembl chr20:3,471,018...3,651,118

G

AXL receptor tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766

G

beta-2-microglobulin

protein:increased expression:urine

RGD

NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851

G

beta-1,4-galactosyltransferase 5

CTD Direct Evidence: marker/mechanism

NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878

G

B9 domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:19,334,695...19,377,913
Ensembl chr17:19,334,308...19,378,193

G

BCL2 antagonist/killer 1

mRNA:increased expression:liver

RGD

NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293

G

gamma-butyrobetaine hydroxylase 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809

G

BCL2 apoptosis regulator

treatment

mRNA:increased expression:liver (rat)

RGD

PMID:24218972 PMID:17938867

RGD:10054116, RGD:2293129

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

BCR activator of RhoGEF and GTPase

CTD Direct Evidence: marker/mechanism

NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037

G

3-hydroxybutyrate dehydrogenase 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323

G

biglycan

CTD Direct Evidence: marker/mechanism

NCBI chr X:153,494,980...153,509,546
Ensembl chr X:153,494,980...153,509,546

G

BICD cargo adaptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:92,711,363...92,764,833
Ensembl chr 9:92,711,363...92,764,833

G

baculoviral IAP repeat containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403

G

baculoviral IAP repeat containing 5

RGD

NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636

G

biogenesis of lysosomal organelles complex 1 subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:100,273,278...100,286,680
Ensembl chr10:100,273,280...100,286,680

G

biliverdin reductase A

CTD Direct Evidence: marker/mechanism

NCBI chr 7:43,758,122...43,807,342
Ensembl chr 7:43,758,680...43,807,342

G

Bcl2 modifying factor

CTD Direct Evidence: marker/mechanism

NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892

G

bone morphogenetic protein 4

mRNA, protein:increased expression:liver

RGD

NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761

G

bone morphogenetic protein 7

CTD Direct Evidence: therapeutic

NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641

G

chromosome 11 open reading frame 54

CTD Direct Evidence: marker/mechanism

NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749

G

chromosome 1 open reading frame 21

CTD Direct Evidence: marker/mechanism

NCBI chr 1:184,387,029...184,629,019
Ensembl chr 1:184,387,029...184,629,019

G

chromosome 1 open reading frame 210

CTD Direct Evidence: marker/mechanism

NCBI chr 1:43,281,877...43,285,857
Ensembl chr 1:43,281,877...43,285,617

G

complement C1q A chain

CTD Direct Evidence: marker/mechanism

NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678

G

complement C1q B chain

CTD Direct Evidence: marker/mechanism

NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637

G

complement C1q C chain

CTD Direct Evidence: marker/mechanism

NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110

G

chromosome 3 open reading frame 70

CTD Direct Evidence: marker/mechanism

NCBI chr 3:185,076,838...185,153,060
Ensembl chr 3:185,076,838...185,153,060

G

complement C5a receptor 1

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:15995705

NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066

G

complement C7

CTD Direct Evidence: marker/mechanism

NCBI chr 5:40,909,497...40,984,643
Ensembl chr 5:40,909,492...41,020,216

G

complement C8 gamma chain

CTD Direct Evidence: marker/mechanism

NCBI chr 9:136,945,243...136,946,975
Ensembl chr 9:136,945,185...136,946,975

G

carbonic anhydrase 3

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040

G

carbonic anhydrase 5A

CTD Direct Evidence: marker/mechanism

NCBI chr16:87,881,549...87,936,529
Ensembl chr16:87,881,546...87,936,580

G

calcium/calmodulin dependent protein kinase II delta

CTD Direct Evidence: marker/mechanism

NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927

G

capping actin protein, gelsolin like

CTD Direct Evidence: marker/mechanism

NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432

G

caspase 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250

G

caspase 12 (gene/pseudogene)

protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:16092975

NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670

G

caspase 4

CTD Direct Evidence: marker/mechanism

NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366

G

caspase 7

CTD Direct Evidence: marker/mechanism

NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907

G

caveolin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179

G

coiled-coil domain containing 126

CTD Direct Evidence: marker/mechanism

NCBI chr 7:23,597,382...23,644,708
Ensembl chr 7:23,597,382...23,644,708

G

C-C motif chemokine ligand 15

CTD Direct Evidence: marker/mechanism

NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553

G

C-C motif chemokine ligand 2

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15492853 PMID:19144177 PMID:15492853 PMID:28437891

RGD:2307001, RGD:8549576, RGD:14995945

NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208

G

C-C motif chemokine ligand 5

severity
disease_progression
treatment

CTD Direct Evidence: marker/mechanism
mRNA,protein:increased expression:liver

CTD
RGD

PMID:25380136 PMID:20978355 PMID:20978355 PMID:25617348 PMID:22574195

RGD:14995328, RGD:14995328, RGD:14995329, RGD:14995337

NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793

G

C-C motif chemokine ligand 7

RGD

NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242

G

cellular communication network factor 2

mRNA:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:19856102

NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372

G

cellular communication network factor 4

RGD

NCBI chr 8:133,191,039...133,231,690
Ensembl chr 8:133,191,039...133,231,690

G

cyclin A2

CTD Direct Evidence: marker/mechanism

NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883

G

cyclin B2

CTD Direct Evidence: marker/mechanism

NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045

G

cyclin G1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199

G

C-C motif chemokine receptor 5

treatment

mRNA,protein:increased expression:liver

RGD

PMID:19603542 PMID:19603542

RGD:14401743, RGD:14401743

NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206

G

CD163 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893

G

CD200 receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:112,921,205...112,975,103
Ensembl chr 3:112,921,205...112,975,103

G

CD24 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627

G

CD276 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr15:73,683,944...73,714,514
Ensembl chr15:73,683,966...73,714,514

G

CD36 molecule (CD36 blood group)

CTD Direct Evidence: marker/mechanism

NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277

G

CD38 molecule

mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:16343077

NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232

G

CD48 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 1:160,678,746...160,711,822
Ensembl chr 1:160,678,746...160,711,831

G

CD53 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 1:110,871,210...110,899,922
Ensembl chr 1:110,871,188...110,899,936

G

CD5 molecule like

CTD Direct Evidence: marker/mechanism

NCBI chr 1:157,827,068...157,841,808
Ensembl chr 1:157,830,911...157,898,256

G

CD63 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707

G

CD68 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111

G

CD7 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr17:82,314,873...82,317,608
Ensembl chr17:82,313,564...82,317,608

G

CD74 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969

G

CD83 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,140,682

G

CD86 molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139

G

CDC42 small effector 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:151,050,985...151,059,622
Ensembl chr 1:151,050,971...151,070,325

G

cadherin 1

associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)

RGD

NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537

G

cadherin 5

CTD Direct Evidence: marker/mechanism

NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784

G

cyclin dependent kinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852

G

cyclin dependent kinase 2

RGD

NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789

G

cyclin dependent kinase 4

RGD

NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013

G

cyclin dependent kinase inhibitor 1A

CTD Direct Evidence: marker/mechanism

NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397

G

CDKN2A interacting protein N-terminal like

CTD Direct Evidence: marker/mechanism

NCBI chr 5:134,402,065...134,411,881
Ensembl chr 5:134,402,065...134,411,881

G

cyclin dependent kinase inhibitor 3

CTD Direct Evidence: marker/mechanism

NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218

G

cysteine dioxygenase type 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:115,804,733...115,816,659
Ensembl chr 5:115,804,733...115,816,659

G

CCAAT enhancer binding protein delta

CTD Direct Evidence: marker/mechanism

NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164

G

chymotrypsin like elastase 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679

G

CUGBP Elav-like family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr10:10,462,550...11,336,675
Ensembl chr10:10,798,397...11,336,675

G

cell migration inducing hyaluronidase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:71,683,366...71,769,466
Ensembl chr 9:71,683,366...71,816,690

G

ceramide kinase

CTD Direct Evidence: marker/mechanism

NCBI chr22:46,684,410...46,738,252
Ensembl chr22:46,684,410...46,738,252

G

carboxylesterase 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096

G

carboxylesterase 3

CTD Direct Evidence: marker/mechanism

NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149

G

complement factor D

CTD Direct Evidence: marker/mechanism

NCBI chr19:859,664...863,641
Ensembl chr19:859,453...867,884

G

complement factor properdin

CTD Direct Evidence: marker/mechanism

NCBI chr X:47,623,282...47,630,305
Ensembl chr X:47,623,172...47,630,305

G

chondroitin sulfate synthase 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:101,175,727...101,252,048
Ensembl chr15:101,175,727...101,252,048

G

cell death inducing DFFA like effector a

CTD Direct Evidence: marker/mechanism

NCBI chr18:12,254,361...12,277,595
Ensembl chr18:12,254,361...12,277,595

G

chemokine like factor

CTD Direct Evidence: marker/mechanism

NCBI chr16:66,552,563...66,566,287
Ensembl chr16:66,552,563...66,566,251

G

C-type lectin domain family 4 member A

CTD Direct Evidence: marker/mechanism

NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607

G

C-type lectin domain family 4 member F

CTD Direct Evidence: marker/mechanism

NCBI chr 2:70,808,643...70,825,235
Ensembl chr 2:70,808,643...70,820,599

G

chloride intracellular channel 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:31,730,581...31,737,318
Ensembl chr 6:31,730,581...31,739,763

G

chloride intracellular channel 2

CTD Direct Evidence: marker/mechanism

NCBI chr X:155,276,211...155,334,614
Ensembl chr X:155,276,211...155,334,657

G

cleavage factor polyribonucleotide kinase subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:57,657,762...57,661,865
Ensembl chr11:57,648,188...57,661,865

G

CKLF like MARVEL transmembrane domain containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr16:66,603,996...66,613,892
Ensembl chr16:66,603,874...66,613,892

G

carnosine dipeptidase 1

CTD Direct Evidence: marker/mechanism

NCBI chr18:74,534,500...74,587,212
Ensembl chr18:74,534,500...74,587,212

G

2',3'-cyclic nucleotide 3' phosphodiesterase

CTD Direct Evidence: marker/mechanism

NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740

G

canopy FGF signaling regulator 4

CTD Direct Evidence: marker/mechanism

NCBI chr 7:100,119,634...100,125,508
Ensembl chr 7:100,119,634...100,125,508

G

cannabinoid receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347

G

collagen type XII alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chr 6:75,084,326...75,206,053
Ensembl chr 6:75,084,326...75,206,267

G

collagen type I alpha 1 chain

treatment

protein:increased expression:liver
mRNA, protein:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:26435214 PMID:26739621 PMID:16009107 PMID:20818932 More...

RGD:1601595, RGD:5688339, RGD:8552710, RGD:8552768, RGD:151665755

NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632

G

collagen type I alpha 2 chain

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:7512265

NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227

G

collagen type III alpha 1 chain

CTD Direct Evidence: marker/mechanism

PMID:11788567 PMID:25380136

NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746

G

collagen type IV alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202

G

collagen type IV alpha 2 chain

CTD Direct Evidence: marker/mechanism

NCBI chr13:110,307,284...110,513,209
Ensembl chr13:110,305,812...110,513,209

G

collagen type V alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843

G

collagen type V alpha 2 chain

CTD Direct Evidence: marker/mechanism

NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312

G

collagen type VI alpha 1 chain

CTD Direct Evidence: marker/mechanism

NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050

G

collagen type VI alpha 2 chain

Protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:7791542

NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848

G

collectin subfamily member 12

CTD Direct Evidence: marker/mechanism

NCBI chr18:316,737...500,701
Ensembl chr18:316,737...500,722

G

coenzyme Q10A

CTD Direct Evidence: marker/mechanism

NCBI chr12:56,266,942...56,270,966
Ensembl chr12:56,266,890...56,270,966

G

coactosin like F-actin binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:84,565,596...84,618,078
Ensembl chr16:84,565,596...84,618,078

G

carboxypeptidase Q

CTD Direct Evidence: marker/mechanism

NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654

G

carbamoyl-phosphate synthase 1

mRNA:decreased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15650968 PMID:17539997

NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107

G

cAMP responsive element binding protein 1

associated with Chemical and Drug Induced Liver Injury

RGD

NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988

G

carnitine O-octanoyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 7:87,345,664...87,399,794
Ensembl chr 7:87,345,664...87,399,794

G

C-reactive protein

protein:decreased expression:serum:

RGD

NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589

G

cartilage associated protein

CTD Direct Evidence: marker/mechanism

NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773

G

cryptochrome circadian regulator 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549

G

crystallin alpha B

CTD Direct Evidence: marker/mechanism

NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722

G

cysteine sulfinic acid decarboxylase

CTD Direct Evidence: marker/mechanism

NCBI chr12:53,157,663...53,181,351
Ensembl chr12:53,157,663...53,180,925

G

colony stimulating factor 1 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372

G

colony stimulating factor 3

CTD Direct Evidence: therapeutic

NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813

G

chondroitin sulfate N-acetylgalactosaminyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:19,404,161...19,757,908
Ensembl chr 8:19,404,161...19,758,029

G

cathepsin E

CTD Direct Evidence: marker/mechanism

NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909

G

cathepsin S

CTD Direct Evidence: marker/mechanism

NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957

G

cathepsin Z

CTD Direct Evidence: marker/mechanism

NCBI chr20:58,995,185...59,007,254
Ensembl chr20:58,985,686...59,008,238

G

CTTNBP2 N-terminal like

CTD Direct Evidence: marker/mechanism

NCBI chr 1:112,391,087...112,461,164
Ensembl chr 1:112,396,214...112,463,456

G

CXADR Ig-like cell adhesion molecule

CTD Direct Evidence: marker/mechanism

NCBI chr21:17,513,043...17,636,262
Ensembl chr21:17,513,043...17,593,579

G

C-X-C motif chemokine ligand 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308

G

C-X-C motif chemokine ligand 10

CTD Direct Evidence: marker/mechanism

NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497

G

C-X-C motif chemokine ligand 12

CTD Direct Evidence: marker/mechanism

NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493

G

C-X-C motif chemokine ligand 13

CTD Direct Evidence: marker/mechanism

NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834

G

C-X-C motif chemokine ligand 16

CTD Direct Evidence: marker/mechanism

NCBI chr17:4,733,533...4,739,928
Ensembl chr17:4,733,533...4,739,928

G

C-X-C motif chemokine ligand 9

CTD Direct Evidence: marker/mechanism

NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509

G

cytochrome b-245 alpha chain

CTD Direct Evidence: marker/mechanism

NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083

G

cytochrome b-245 beta chain

CTD Direct Evidence: marker/mechanism

NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461

G

cytoglobin

CTD Direct Evidence: therapeutic

NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175

G

cytochrome P450 family 17 subfamily A member 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472

G

cytochrome P450 family 1 subfamily A member 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607

G

cytochrome P450 family 26 subfamily A member 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:93,073,475...93,077,885
Ensembl chr10:93,073,475...93,077,885

G

cytochrome P450 family 2 subfamily C member 18

CTD Direct Evidence: marker/mechanism

NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190

G

cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)

CTD Direct Evidence: marker/mechanism

NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865

G

cytochrome P450 family 3 subfamily A member 5

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996

G

cytochrome P450 family 7 subfamily A member 1

treatment

RGD

NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163

G

CYFIP related Rac1 interactor A

CTD Direct Evidence: marker/mechanism

NCBI chr 2:16,549,459...16,665,834
Ensembl chr 2:16,549,459...16,666,331

G

CYFIP related Rac1 interactor B

CTD Direct Evidence: marker/mechanism

NCBI chr 8:129,839,593...130,017,129
Ensembl chr 8:129,839,593...130,017,504

G

cysteine rich transmembrane module containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:140,175,188...140,243,789
Ensembl chr 5:140,175,156...140,282,052

G

dystroglycan 1

mRNA:increased expression:liver

RGD

NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618

G

D-amino acid oxidase

CTD Direct Evidence: marker/mechanism

NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043

G

dopamine beta-hydroxylase

mRNA:decreased expression:superior mesenteric artery (rat)

RGD

NCBI chr 9:133,636,363...133,659,329
Ensembl chr 9:133,636,363...133,659,329

G

dysbindin domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr20:45,405,993...45,410,610
Ensembl chr20:45,406,057...45,410,610

G

dicarbonyl and L-xylulose reductase

CTD Direct Evidence: marker/mechanism

NCBI chr17:82,035,858...82,037,697
Ensembl chr17:82,035,136...82,037,709

G

dopa decarboxylase

mRNA:decreased expression:superior mesenteric artery (rat)
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:18457899

NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405

G

DEP domain containing 7

CTD Direct Evidence: marker/mechanism

NCBI chr11:33,015,878...33,033,582
Ensembl chr11:33,015,876...33,033,582

G

dehydrogenase/reductase 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,909...12,620,133

G

dehydrogenase/reductase 7

CTD Direct Evidence: marker/mechanism

NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856

G

dehydrogenase E1 and transketolase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:12,068,954...12,123,221
Ensembl chr10:12,068,954...12,123,221

G

iodothyronine deiodinase 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086

G

divergent protein kinase domain 2A

CTD Direct Evidence: marker/mechanism

NCBI chr 3:143,971,798...143,992,368
Ensembl chr 3:143,971,823...144,048,719

G

dedicator of cytokinesis 10

CTD Direct Evidence: marker/mechanism

NCBI chr 2:224,765,090...225,042,468
Ensembl chr 2:224,765,090...225,042,468

G

dedicator of cytokinesis 7

CTD Direct Evidence: marker/mechanism

NCBI chr 1:62,454,726...62,688,386
Ensembl chr 1:62,454,298...62,688,386

G

dipeptidyl peptidase 7

CTD Direct Evidence: marker/mechanism

NCBI chr 9:137,110,546...137,118,306
Ensembl chr 9:137,110,542...137,118,309

G

dihydropyrimidinase

CTD Direct Evidence: marker/mechanism

NCBI chr 8:104,379,431...104,467,055
Ensembl chr 8:104,330,324...104,467,055

G

DNA damage regulated autophagy modulator 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:101,877,580...101,923,612
Ensembl chr12:101,877,580...102,012,130

G

dihydrouridine synthase 1 like

CTD Direct Evidence: marker/mechanism

NCBI chr17:82,057,506...82,065,804
Ensembl chr17:82,057,506...82,065,887

G

dual specificity phosphatase 16

CTD Direct Evidence: marker/mechanism

NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863

G

dual specificity phosphatase 6

CTD Direct Evidence: marker/mechanism

NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501

G

dysferlin

CTD Direct Evidence: marker/mechanism

NCBI chr 2:71,453,561...71,686,763
Ensembl chr 2:71,453,561...71,686,763

G

endothelin converting enzyme 1

protein:increased expression:liver

RGD

NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572

G

epithelial cell transforming 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474

G

endothelin 1

CTD Direct Evidence: therapeutic

NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194

G

EEIG family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:108,560,100...108,639,322
Ensembl chr 1:108,560,089...108,644,900

G

epidermal growth factor

CTD Direct Evidence: marker/mechanism

NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766

G

eukaryotic translation initiation factor 4E family member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:71,659,363...71,754,773
Ensembl chr 3:71,675,414...71,754,773

G

ELOVL fatty acid elongase 5

CTD Direct Evidence: marker/mechanism

NCBI chr 6:53,267,404...53,348,950
Ensembl chr 6:53,267,398...53,349,179

G

embigin

CTD Direct Evidence: marker/mechanism

NCBI chr 5:50,396,192...50,443,345
Ensembl chr 5:50,396,192...50,443,248

G

epithelial membrane protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941

G

ectodermal-neural cortex 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424

G

glutamyl aminopeptidase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:110,476,155...110,565,285
Ensembl chr 4:110,365,733...110,565,285

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

treatment

protein:increased activity:serum:
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17072980 PMID:17850827 PMID:20957682

RGD:9685426, RGD:9685427

NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453

G

ectonucleoside triphosphate diphosphohydrolase 2

RGD

NCBI chr 9:137,048,107...137,054,061
Ensembl chr 9:137,048,107...137,054,061

G

erythrocyte membrane protein band 4.1 like 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:130,839,347...131,063,245
Ensembl chr 6:130,839,347...131,063,322

G

epithelial cell adhesion molecule

CTD Direct Evidence: marker/mechanism

NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601

G

endoplasmic reticulum aminopeptidase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100

G

endoplasmic reticulum to nucleus signaling 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819

G

exostosin like glycosyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:26,021,775...26,036,464
Ensembl chr 1:26,019,884...26,036,464

G

ezrin

CTD Direct Evidence: marker/mechanism

NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368

G

coagulation factor II thrombin receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770

G

coagulation factor V

treatment

RGD

NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588

G

fatty acid binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138

G

fatty acid binding protein 7

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074

G

fumarylacetoacetate hydrolase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:1,827,206...1,840,207
Ensembl chr16:1,826,967...1,840,207

G

family with sequence similarity 167 member B

CTD Direct Evidence: marker/mechanism

NCBI chr 1:32,247,222...32,248,856
Ensembl chr 1:32,247,222...32,248,856

G

family with sequence similarity 43 member A

CTD Direct Evidence: marker/mechanism

NCBI chr 3:194,685,883...194,689,037
Ensembl chr 3:194,685,883...194,689,037

G

family with sequence similarity 89 member A

CTD Direct Evidence: marker/mechanism

NCBI chr 1:231,018,958...231,040,254
Ensembl chr 1:231,018,958...231,040,254

G

Fas cell surface death receptor

mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:30737368 PMID:17105443

NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605

G

FAT atypical cadherin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,794...186,726,722

G

fibrillin 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721

G

F-box protein 9

CTD Direct Evidence: marker/mechanism

NCBI chr 6:53,064,998...53,100,873
Ensembl chr 6:53,051,991...53,100,873

G

Fc epsilon receptor Ig

CTD Direct Evidence: marker/mechanism

NCBI chr 1:161,215,295...161,219,245
Ensembl chr 1:161,215,234...161,220,699

G

Fc gamma receptor Ia

CTD Direct Evidence: marker/mechanism

NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675

G

Fc gamma receptor IIIa

CTD Direct Evidence: marker/mechanism

NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968

G

ficolin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:134,903,232...134,917,912
Ensembl chr 9:134,903,232...134,917,912

G

fibroblast growth factor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236

G

fibroblast growth factor receptor 1

treatment

RGD

NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834

G

fibrinogen gamma chain

mRNA:increased expression

RGD

NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967

G

fibrinogen like 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848

G

FGR proto-oncogene, Src family tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 1:27,612,064...27,635,185
Ensembl chr 1:27,612,064...27,635,185

G

four and a half LIM domains 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359

G

four and a half LIM domains 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513

G

FKBP prolyl isomerase 1A

CTD Direct Evidence: marker/mechanism

NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164

G

Fli-1 proto-oncogene, ETS transcription factor

CTD Direct Evidence: marker/mechanism

NCBI chr11:128,685,351...128,813,267
Ensembl chr11:128,686,535...128,813,267

G

filamin A

CTD Direct Evidence: marker/mechanism

NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634

G

formin like 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:45,221,885...45,247,318
Ensembl chr17:45,221,444...45,247,319

G

formin like 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:152,335,174...152,649,826
Ensembl chr 2:152,335,174...152,649,826

G

flavin containing dimethylaniline monoxygenase 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978

G

fibronectin 1

treatment

mRNA:increased expression:liver:
mRNA:altered expression:liver (rat)

RGD

PMID:19914391 PMID:15980055

RGD:4140452, RGD:1625201

NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073

G

folate receptor beta

CTD Direct Evidence: marker/mechanism

NCBI chr11:72,216,794...72,221,950
Ensembl chr11:72,216,601...72,221,950

G

Fos proto-oncogene, AP-1 transcription factor subunit

CTD Direct Evidence: marker/mechanism

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190

G

forkhead box A2

CTD Direct Evidence: marker/mechanism

NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455

G

forkhead box O1

associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)

RGD

NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641

G

FRY microtubule binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr13:32,031,774...32,299,125
Ensembl chr13:31,846,713...32,299,125

G

follistatin like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016

G

formimidoyltransferase cyclodeaminase

CTD Direct Evidence: marker/mechanism

NCBI chr21:46,136,262...46,155,579
Ensembl chr21:46,136,160...46,155,579

G

FXYD domain containing ion transport regulator 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698

G

FXYD domain containing ion transport regulator 5

CTD Direct Evidence: marker/mechanism

NCBI chr19:35,154,735...35,169,881
Ensembl chr19:35,154,730...35,171,791

G

FXYD domain containing ion transport regulator 6

CTD Direct Evidence: marker/mechanism

NCBI chr11:117,836,981...117,877,430
Ensembl chr11:117,836,976...117,877,486

G

FYN proto-oncogene, Src family tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452

G

frizzled class receptor 8

CTD Direct Evidence: marker/mechanism

NCBI chr10:35,638,247...35,642,296
Ensembl chr10:35,638,247...35,642,296

G

G0/G1 switch 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390

G

glucose-6-phosphatase catalytic subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438

G

GRB2 associated binding protein 1

protein:increased tyrosine phosphorylation: :

RGD

NCBI chr 4:143,336,876...143,474,565
Ensembl chr 4:143,336,876...143,474,565

G

galactosylceramidase

CTD Direct Evidence: marker/mechanism

NCBI chr14:87,933,014...87,993,667
Ensembl chr14:87,837,820...87,993,665

G

golgi associated kinase 1B

CTD Direct Evidence: marker/mechanism

NCBI chr 4:158,124,474...158,173,025
Ensembl chr 4:158,124,474...158,173,318

G

guanylate binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:89,106,132...89,126,114
Ensembl chr 1:89,106,132...89,150,456

G

guanylate binding protein 4

CTD Direct Evidence: marker/mechanism

NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942

G

GC vitamin D binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041

G

glycine C-acetyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr22:37,807,934...37,817,183
Ensembl chr22:37,807,905...37,817,176

G

GTP cyclohydrolase I feedback regulator

CTD Direct Evidence: marker/mechanism

NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708

G

glucokinase

CTD Direct Evidence: marker/mechanism

NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170

G

glucosaminyl (N-acetyl) transferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:76,393,869...76,507,416
Ensembl chr 9:76,419,850...76,651,203

G

guided entry of tail-anchored proteins factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr21:39,380,326...39,428,528
Ensembl chr21:39,377,698...39,428,528

G

glial fibrillary acidic protein

associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat)

RGD

NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937

G

GDNF family receptor alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803

G

gamma-glutamyl hydrolase

CTD Direct Evidence: marker/mechanism

NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407

G

glycoprotein alpha-galactosyltransferase 1 (inactive)

CTD Direct Evidence: marker/mechanism

NCBI chr 9:121,444,990...121,499,844
Ensembl chr 9:121,444,991...121,499,844

G

growth hormone 1

CTD Direct Evidence: therapeutic

NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839

G

growth hormone receptor

mRNA, protein:decreased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17072980 PMID:25380136 PMID:12679928

NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878

G

gap junction protein alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727

G

gap junction protein alpha 4

CTD Direct Evidence: marker/mechanism

NCBI chr 1:34,792,999...34,795,747
Ensembl chr 1:34,792,999...34,795,747

G

glycerol kinase

CTD Direct Evidence: marker/mechanism

NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462

G

GLI pathogenesis related 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863

G

glutaminase

CTD Direct Evidence: marker/mechanism

NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552

G

glutaminase 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414

G

glycosyltransferase 8 domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:52,694,486...52,705,791
Ensembl chr 3:52,694,486...52,706,032

G

glia maturation factor gamma

CTD Direct Evidence: marker/mechanism

NCBI chr19:39,328,359...39,336,043
Ensembl chr19:39,328,353...39,342,372

G

G protein subunit alpha 14

CTD Direct Evidence: marker/mechanism

NCBI chr 9:77,423,079...77,648,322
Ensembl chr 9:77,423,079...77,648,322

G

G protein subunit alpha i2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362

G

G protein subunit gamma transducin 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:49,206,234...49,210,574
Ensembl chr17:49,202,791...49,210,574

G

glucosamine-6-phosphate deaminase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:142,000,671...142,013,027
Ensembl chr 5:141,991,749...142,013,041

G

glutamic-oxaloacetic transaminase 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624

G

glycerol-3-phosphate acyltransferase, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377

G

glycoprotein nmb

CTD Direct Evidence: marker/mechanism

NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108

G

G protein-coupled receptor 68

CTD Direct Evidence: marker/mechanism

NCBI chr14:91,232,532...91,270,790
Ensembl chr14:91,232,532...91,253,925

G

glutamic--pyruvic transaminase

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:17072980 PMID:22706148

NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174

G

glutathione peroxidase 8 (putative)

CTD Direct Evidence: marker/mechanism

NCBI chr 5:55,160,171...55,167,297
Ensembl chr 5:55,160,167...55,167,297

G

G protein-coupled receptor kinase 2

protein:increased expression:aorta

RGD

NCBI chr11:67,266,473...67,286,556
Ensembl chr11:67,266,473...67,286,556

G

granulin precursor

CTD Direct Evidence: marker/mechanism

NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106

G

gelsolin

mRNA, protein:increased expression
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:14574581

NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843

G

glutathione S-transferase alpha 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475

G

glutathione S-transferase alpha 3

CTD Direct Evidence: marker/mechanism

NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698

G

glutathione S-transferase alpha 4

treatment

RGD

NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304

G

glutathione S-transferase mu 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039

G

gulonolactone (L-) oxidase, pseudogene

CTD Direct Evidence: marker/mechanism

NCBI chr 8:27,577,611...27,589,073
Ensembl chr 8:27,560,274...27,589,073

G

GULP PTB domain containing engulfment adaptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931

G

granzyme A

CTD Direct Evidence: marker/mechanism

NCBI chr 5:55,102,646...55,110,252
Ensembl chr 5:55,102,646...55,110,252

G

hydroxyacylglutathione hydrolase

CTD Direct Evidence: marker/mechanism

NCBI chr16:1,807,629...1,827,194
Ensembl chr16:1,795,620...1,827,157

G

histidine ammonia-lyase

CTD Direct Evidence: marker/mechanism

NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365

G

hydroxyacid oxidase 1

CTD Direct Evidence: marker/mechanism

NCBI chr20:7,882,985...7,940,458
Ensembl chr20:7,882,985...7,940,458

G

hydroxyacid oxidase 2

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130

G

HCK proto-oncogene, Src family tyrosine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856

G

helicase, lymphoid specific

CTD Direct Evidence: marker/mechanism

NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905

G

HEXIM P-TEFb complex subunit 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:45,148,475...45,152,099
Ensembl chr17:45,148,475...45,152,099

G

hepatocyte growth factor

CTD Direct Evidence: therapeutic

PMID:10677585 PMID:12918455 PMID:15793283 PMID:16465399 PMID:16627068 More...

NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438

G

huntingtin interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:75,533,298...75,738,941
Ensembl chr 7:75,533,298...75,738,962

G

hemojuvelin BMP co-receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746

G

major histocompatibility complex, class II, DM alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094

G

major histocompatibility complex, class II, DM beta

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028

G

major histocompatibility complex, class II, DQ alpha 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062

G

major histocompatibility complex, class II, DR alpha

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046

G

major histocompatibility complex, class II, DR beta 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848

G

major histocompatibility complex, class I, F

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528

G

major histocompatibility complex, class I, G

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125

G

3-hydroxy-3-methylglutaryl-CoA reductase

CTD Direct Evidence: marker/mechanism

NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001

G

heme oxygenase 1

CTD Direct Evidence: marker/mechanism|therapeutic

CTD
RGD

PMID:16025519 PMID:16610050 PMID:21163135 PMID:25380136 PMID:19554654

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

HOP homeobox

CTD Direct Evidence: marker/mechanism

NCBI chr 4:56,647,998...56,681,706
Ensembl chr 4:56,647,989...56,681,877

G

homeobox A3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:27,107,010...27,152,583
Ensembl chr 7:27,106,184...27,152,583

G

haptoglobin

protein:increased expression:serum
protein:decreased expression:serum

RGD

PMID:16968543 PMID:21806828

RGD:1626367, RGD:9491781

NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055

G

hippocalcin like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:10,302,904...10,427,604
Ensembl chr 2:10,302,889...10,427,617

G

hematopoietic prostaglandin D synthase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876

G

heparanase

CTD Direct Evidence: marker/mechanism

PMID:15095483 PMID:18458672

NCBI chr 4:83,292,461...83,335,153
Ensembl chr 4:83,292,461...83,335,153

G

hydroxysteroid 17-beta dehydrogenase 2

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534

G

hydroxysteroid 17-beta dehydrogenase 6

CTD Direct Evidence: marker/mechanism

NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,752,161...56,787,790

G

5-hydroxytryptamine receptor 2B

protein:increased expression:liver (rat)

RGD

NCBI chr 2:231,108,230...231,125,042
Ensembl chr 2:231,108,230...231,125,042

G

hydroxylysine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr15:78,507,577...78,537,373
Ensembl chr15:78,507,564...78,537,372

G

intercellular adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:64,002,595...64,020,633
Ensembl chr17:64,002,594...64,020,634

G

inhibitor of DNA binding 2

CTD Direct Evidence: therapeutic

NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461

G

inhibitor of DNA binding 4

CTD Direct Evidence: marker/mechanism

NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197

G

indoleamine 2,3-dioxygenase 1

severity

protein:increased expression:serum (mouse)

RGD

PMID:28465467 PMID:28465467

RGD:39939037, RGD:39939037

NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790

G

alpha-L-iduronidase

protein:increased expression:liver

RGD

NCBI chr 4:986,997...1,008,351
Ensembl chr 4:986,997...1,004,564

G

interferon gamma inducible protein 16

CTD Direct Evidence: marker/mechanism

NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155

G

interferon induced protein 35

CTD Direct Evidence: marker/mechanism

NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456

G

interferon induced transmembrane protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:314,040...315,272
Ensembl chr11:310,041...315,272

G

interferon alpha 1

CTD Direct Evidence: therapeutic

PMID:12898905 PMID:14512876 PMID:16027843

NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316

G

interferon alpha 2

CTD Direct Evidence: therapeutic

NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398

G

interferon gamma

CTD Direct Evidence: therapeutic
protein:increased expression:serum (mouse)

CTD
RGD

PMID:12389079 PMID:15996030 PMID:16953842 PMID:17347453 PMID:28465467

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

interferon gamma receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449

G

interferon related developmental regulator 1

CTD Direct Evidence: marker/mechanism

NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017

G

insulin like growth factor 1

treatment

protein:increased expression:liver:
CTD Direct Evidence: therapeutic

CTD
RGD

PMID:15591519 PMID:15745444 PMID:16434425 PMID:12800242 PMID:20198635

RGD:2317647, RGD:10045984, RGD:12904923

NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744

G

insulin like growth factor 1 receptor

protein:increased expression:liver:

RGD

NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530

G

insulin like growth factor 2 mRNA binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:23,310,209...23,470,491
Ensembl chr 7:23,310,209...23,470,491

G

insulin like growth factor 2 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507

G

insulin like growth factor binding protein acid labile subunit

CTD Direct Evidence: marker/mechanism

NCBI chr16:1,790,413...1,794,908
Ensembl chr16:1,790,413...1,794,971

G

insulin like growth factor binding protein 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660

G

insulin like growth factor binding protein 2

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436

G

insulin like growth factor binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874

G

insulin like growth factor binding protein 7

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:25691930

NCBI chr 4:57,030,773...57,110,385
Ensembl chr 4:57,030,773...57,110,385

G

immunoglobulin superfamily member 6

CTD Direct Evidence: marker/mechanism

NCBI chr16:21,639,550...21,652,608
Ensembl chr16:21,639,550...21,652,608

G

inhibitor of nuclear factor kappa B kinase regulatory subunit gamma

CTD Direct Evidence: marker/mechanism

NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046

G

interleukin 10

treatment

CTD Direct Evidence: therapeutic

CTD
RGD

PMID:12632514 PMID:15362042 PMID:16097045 PMID:16126171 PMID:16539848 More...

RGD:7364982, RGD:11049490

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

interleukin 17A

treatment

protein:increased expression:liver, serum (mouse)

RGD

PMID:28465467 PMID:30346985

RGD:39939037, RGD:151665755

NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638

G

interleukin 17 receptor A

treatment

RGD

NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693

G

interleukin 17 receptor C

treatment

RGD

NCBI chr 3:9,917,098...9,933,621
Ensembl chr 3:9,917,074...9,933,630

G

interleukin 18

CTD Direct Evidence: marker/mechanism

NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096

G

interleukin 18 binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315

G

interleukin 1 beta

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16085334 PMID:24383550

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 2

treatment

RGD

NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725

G

interleukin 2 receptor subunit beta

CTD Direct Evidence: marker/mechanism

NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118

G

interleukin 2 receptor subunit gamma

CTD Direct Evidence: marker/mechanism

NCBI chr X:71,107,404...71,111,577
Ensembl chr X:71,107,404...71,112,108

G

interleukin 33

CTD Direct Evidence: marker/mechanism

NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983

G

interleukin 4

protein:decreased expression:serum (mouse)

RGD

NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678

G

interleukin 6

treatment

mRNA:increased expression:liver (mouse)

RGD

PMID:24383550 PMID:28465467 PMID:30346985

RGD:10450610, RGD:39939037, RGD:151665755

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

interleukin 7 receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603

G

integrin linked kinase

CTD Direct Evidence: marker/mechanism

NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874

G

inhibin subunit beta C

CTD Direct Evidence: marker/mechanism

NCBI chr12:57,434,784...57,452,062
Ensembl chr12:57,434,784...57,452,062

G

inhibin subunit beta E

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280

G

indolethylamine N-methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 7:30,752,135...30,757,602
Ensembl chr 7:30,697,985...30,757,602

G

inositol polyphosphate-5-phosphatase D

CTD Direct Evidence: marker/mechanism

NCBI chr 2:233,060,342...233,207,903
Ensembl chr 2:233,059,967...233,207,903

G

inositol polyphosphate phosphatase like 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:72,223,563...72,239,147
Ensembl chr11:72,223,701...72,239,147

G

insulin

CTD Direct Evidence: therapeutic

NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221

G

insulin induced gene 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:118,088,471...118,110,997
Ensembl chr 2:118,088,452...118,110,997

G

IQ motif containing GTPase activating protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:90,388,242...90,502,239
Ensembl chr15:90,388,242...90,502,239

G

interferon regulatory factor 8

CTD Direct Evidence: marker/mechanism

NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606

G

interferon stimulated exonuclease gene 20

CTD Direct Evidence: marker/mechanism

NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483

G

inositol-3-phosphate synthase 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,167

G

integrin subunit alpha 2b

CTD Direct Evidence: marker/mechanism

NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649

G

integrin subunit alpha L

CTD Direct Evidence: marker/mechanism

NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567

G

integrin subunit beta 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792

G

integrin subunit beta 2

CTD Direct Evidence: marker/mechanism

NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989

G

integrin subunit beta 3

CTD Direct Evidence: marker/mechanism

NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743

G

integrin subunit beta 6

mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18221819 PMID:18538673

NCBI chr 2:160,099,671...160,200,272
Ensembl chr 2:160,099,667...160,271,888

G

isovaleryl-CoA dehydrogenase

CTD Direct Evidence: marker/mechanism

NCBI chr15:40,405,795...40,435,947
Ensembl chr15:40,405,485...40,435,947

G

iodotyrosine deiodinase

CTD Direct Evidence: marker/mechanism

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

G

Janus kinase 2

protein:increased expression, increased tyrosine phosphorylation:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:24619965

NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948

G

Jun dimerization protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:75,426,943...75,474,107
Ensembl chr14:75,427,716...75,474,111

G

KN motif and ankyrin repeat domains 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:470,295...746,103
Ensembl chr 9:470,291...746,105

G

potassium inwardly rectifying channel subfamily J member 8

CTD Direct Evidence: marker/mechanism

NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600

G

potassium calcium-activated channel subfamily N member 4

exacerbates

mRNA:increased expression:liver (rat)

RGD

PMID:27354175 PMID:27354175

RGD:329955558, RGD:329955558

NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976

G

KLF transcription factor 6

CTD Direct Evidence: marker/mechanism

NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281

G

kynurenine 3-monooxygenase

CTD Direct Evidence: marker/mechanism

NCBI chr 1:241,532,378...241,595,642
Ensembl chr 1:241,532,134...241,595,642

G

kininogen 1

CTD Direct Evidence: therapeutic

NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410

G

keratin 18

CTD Direct Evidence: marker/mechanism
protein:increased expression:liver, plasma membrane (rat)

CTD
RGD

PMID:15999547 PMID:17072980 PMID:18395095 PMID:25380136 PMID:21138630

NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906

G

keratin 19

CTD Direct Evidence: marker/mechanism

NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308

G

keratin 8

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954

G

kinectin 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526

G

kynureninase

CTD Direct Evidence: marker/mechanism

NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,657...143,055,833

G

trans-L-3-hydroxyproline dehydratase

CTD Direct Evidence: marker/mechanism

NCBI chr14:59,465,478...59,505,273
Ensembl chr14:59,460,363...59,484,408

G

lysosomal protein transmembrane 5

CTD Direct Evidence: marker/mechanism

NCBI chr 1:30,732,469...30,757,774
Ensembl chr 1:30,732,469...30,757,774

G

LBH regulator of WNT signaling pathway

CTD Direct Evidence: marker/mechanism

NCBI chr 2:30,231,534...30,260,028
Ensembl chr 2:30,231,534...30,323,730

G

lipopolysaccharide binding protein

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013

G

lipocalin 2

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453

G

lymphocyte cytosolic protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:46,125,923...46,182,177
Ensembl chr13:46,125,920...46,211,871

G

lymphocyte cytosolic protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 5:170,246,233...170,297,777
Ensembl chr 5:170,246,233...170,297,815

G

lactate dehydrogenase B

CTD Direct Evidence: marker/mechanism

NCBI chr12:21,635,342...21,657,842
Ensembl chr12:21,635,342...21,757,857

G

left-right determination factor 2

ameliorates

RGD

NCBI chr 1:225,936,603...225,941,220
Ensembl chr 1:225,936,598...225,941,383

G

leptin

disease_progression

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:12586293 PMID:16097051 PMID:29248466 PMID:19065677 PMID:20509998

RGD:5128713, RGD:5128589

NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629

G

leptin receptor

protein:increased expression:serum

RGD

NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559

G

galectin 1

CTD Direct Evidence: marker/mechanism

NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802

G

galectin 2

CTD Direct Evidence: marker/mechanism

NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616

G

galectin 3

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16549783 PMID:25380136 PMID:12646584 PMID:16549783

RGD:9685223, RGD:9685224

NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423

G

galectin like

CTD Direct Evidence: marker/mechanism

NCBI chr 2:64,454,162...64,461,381
Ensembl chr 2:64,453,969...64,461,381

G

legumain

CTD Direct Evidence: marker/mechanism

NCBI chr14:92,703,809...92,748,627
Ensembl chr14:92,703,807...92,748,679

G

LHFPL tetraspan subfamily member 6

CTD Direct Evidence: marker/mechanism

NCBI chr13:39,342,892...39,603,193
Ensembl chr13:39,209,116...39,603,528

G

LIM domain kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr22:31,212,298...31,280,080
Ensembl chr22:31,212,239...31,280,080

G

lin-7 homolog A, crumbs cell polarity complex component

CTD Direct Evidence: marker/mechanism

NCBI chr12:80,792,520...80,937,934
Ensembl chr12:80,792,520...80,937,934

G

LIM domain only 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076

G

lysyl oxidase

CTD Direct Evidence: marker/mechanism

NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413

G

lysyl oxidase like 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:23,296,897...23,404,120
Ensembl chr 8:23,296,897...23,425,328

G

lipoprotein lipase

CTD Direct Evidence: marker/mechanism

NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259

G

leupaxin

CTD Direct Evidence: marker/mechanism

NCBI chr11:58,526,871...58,578,891
Ensembl chr11:58,526,871...58,578,220

G

lecithin retinol acyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120

G

LDL receptor related protein 6

RGD

NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044

G

leucine rich repeat containing 28

CTD Direct Evidence: marker/mechanism

NCBI chr15:99,251,481...99,390,729
Ensembl chr15:99,251,362...99,390,729

G

LRR binding FLII interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:237,627,587...237,781,643
Ensembl chr 2:237,627,587...237,813,682

G

leukotriene A4 hydrolase

CTD Direct Evidence: marker/mechanism

NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520

G

lymphotoxin beta

CTD Direct Evidence: marker/mechanism

NCBI chr 6:31,580,558...31,582,425
Ensembl chr 6:31,580,525...31,582,522

G

latent transforming growth factor beta binding protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:32,946,953...33,399,509
Ensembl chr 2:32,946,953...33,399,509

G

lumican

CTD Direct Evidence: marker/mechanism

NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494

G

leucine rich adaptor protein 1 like

CTD Direct Evidence: marker/mechanism

NCBI chr 9:12,775,020...12,823,060
Ensembl chr 9:12,775,020...12,823,060

G

lymphocyte antigen 86

CTD Direct Evidence: marker/mechanism

NCBI chr 6:6,588,720...6,654,982
Ensembl chr 6:6,588,108...6,654,983

G

lymphocyte antigen 96

CTD Direct Evidence: marker/mechanism

NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079

G

MAGE family member E1

CTD Direct Evidence: marker/mechanism

NCBI chr X:76,427,710...76,431,342
Ensembl chr X:76,427,710...76,431,342

G

metastasis associated lung adenocarcinoma transcript 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,606...65,508,073

G

microtubule associated protein 1 light chain 3 alpha

CTD Direct Evidence: marker/mechanism

NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345

G

mitogen-activated protein kinase kinase kinase 8

CTD Direct Evidence: marker/mechanism

NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833

G

mitogen-activated protein kinase 1

treatment

RGD

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 3

treatment

RGD

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

MAS1 proto-oncogene, G protein-coupled receptor

mRNA:increased expression:liver (rat)

RGD

NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447

G

malate dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197

G

mesenchyme homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:15,611,212...15,686,683
Ensembl chr 7:15,611,212...15,686,683

G

MET proto-oncogene, receptor tyrosine kinase

protein:decreased expression:liver (rat)

RGD

NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377

G

meteorin like, glial cell differentiation regulator

CTD Direct Evidence: marker/mechanism

NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122

G

microfibril associated protein 4

CTD Direct Evidence: marker/mechanism

NCBI chr17:19,383,445...19,387,190
Ensembl chr17:19,383,442...19,387,190

G

mitofusin 2

treatment

mRNA, protein:decreased expression:liver (rat)

RGD

PMID:26882442 PMID:25369251

RGD:12910839, RGD:13204798

NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211

G

alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 2:134,119,935...134,454,621
Ensembl chr 2:134,119,983...134,454,621

G

O-6-methylguanine-DNA methyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983

G

matrix Gla protein

CTD Direct Evidence: marker/mechanism

NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857

G

MID1 interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr X:38,801,459...38,806,532
Ensembl chr X:38,801,440...38,806,537

G

macrophage migration inhibitory factor

protein:increased expression:hepatocyte

RGD

NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227

G

MINDY lysine 48 deubiquitinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr10:15,778,174...15,860,507
Ensembl chr10:15,778,170...15,860,507

G

microRNA 122

treatment

RGD

NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158

G

microRNA 152

treatment

miRNA:decreased expression:liver

RGD

PMID:26257392 PMID:31258681

RGD:19165150, RGD:19165153

NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247

G

microRNA 17

treatment

RGD

NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688

G

microRNA 182

associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)

NCBI chr 7:129,770,383...129,770,492
Ensembl chr 7:129,770,383...129,770,492

G

microRNA 223

RNA:increased expression:liver
RNA:increased expression:serum,liver

RGD

PMID:32003753 PMID:31295147 PMID:28646120

RGD:21408545, RGD:21408548, RGD:21408574

NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979

G

microRNA 30a

treatment

RGD

NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621

G

MIS12 kinetochore complex component

CTD Direct Evidence: marker/mechanism

NCBI chr17:5,486,374...5,490,811
Ensembl chr17:5,486,285...5,490,814

G

marker of proliferation Ki-67

CTD Direct Evidence: marker/mechanism

NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423

G

membrane metalloendopeptidase

CTD Direct Evidence: marker/mechanism

NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704

G

matrix metallopeptidase 1

CTD Direct Evidence: therapeutic

NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160

G

matrix metallopeptidase 13

treatment

CTD Direct Evidence: therapeutic

CTD
RGD

PMID:17404313 PMID:10623612

NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732

G

matrix metallopeptidase 15

CTD Direct Evidence: marker/mechanism

NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901

G

matrix metallopeptidase 2

CTD Direct Evidence: marker/mechanism

PMID:15095483 PMID:25380136

NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691

G

matrix metallopeptidase 3

RGD

NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609

G

matrix metallopeptidase 8

CTD Direct Evidence: therapeutic

NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050

G

matrix metallopeptidase 9

CTD Direct Evidence: marker/mechanism

NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561

G

MOB kinase activator 3A

CTD Direct Evidence: marker/mechanism

NCBI chr19:2,071,036...2,096,515
Ensembl chr19:2,071,036...2,096,673

G

maestro

CTD Direct Evidence: marker/mechanism

NCBI chr18:50,795,130...50,825,380
Ensembl chr18:50,795,120...50,825,402

G

moesin

CTD Direct Evidence: marker/mechanism

NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931

G

mitochondrially encoded cytochrome b

protein:increased expression:mitochondrion, liver

RGD

NCBI chr MT:14,747...15,887
Ensembl chr MT:14,747...15,887

G

metallothionein 1A

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087

G

metallothionein 2A

CTD Direct Evidence: marker/mechanism

NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497

G

myotubularin related protein 7

CTD Direct Evidence: marker/mechanism

NCBI chr 8:17,296,794...17,413,351
Ensembl chr 8:17,296,794...17,413,528

G

mechanistic target of rapamycin kinase

treatment

RGD

NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556

G

major vault protein

CTD Direct Evidence: marker/mechanism

NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039

G

myeloid associated differentiation marker

CTD Direct Evidence: marker/mechanism

NCBI chr19:53,865,628...53,876,435
Ensembl chr19:53,864,763...53,878,125

G

MYC proto-oncogene, bHLH transcription factor

CTD Direct Evidence: marker/mechanism

NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951

G

myosin light chain 9

CTD Direct Evidence: marker/mechanism

NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447

G

myosin IC

CTD Direct Evidence: marker/mechanism

NCBI chr17:1,464,186...1,492,686
Ensembl chr17:1,464,186...1,492,686

G

myosin IF

CTD Direct Evidence: marker/mechanism

NCBI chr19:8,520,778...8,577,442
Ensembl chr19:8,517,463...8,577,442

G

myosin VA

CTD Direct Evidence: marker/mechanism

NCBI chr15:52,307,283...52,529,050
Ensembl chr15:52,307,281...52,529,132

G

myocilin

CTD Direct Evidence: marker/mechanism

NCBI chr 1:171,635,417...171,652,688
Ensembl chr 1:171,635,417...171,652,688

G

N-acetylglucosamine kinase

CTD Direct Evidence: marker/mechanism

NCBI chr 2:71,068,296...71,079,808
Ensembl chr 2:71,064,344...71,079,808

G

nucleosome assembly protein 1 like 5

CTD Direct Evidence: marker/mechanism

NCBI chr 4:88,695,913...88,697,829
Ensembl chr 4:88,695,913...88,697,829

G

N-acetyltransferase 8 (putative)

CTD Direct Evidence: marker/mechanism

NCBI chr 2:73,640,723...73,642,422
Ensembl chr 2:73,640,723...73,642,422

G

neurobeachin

CTD Direct Evidence: marker/mechanism

NCBI chr13:34,942,270...35,672,736
Ensembl chr13:34,942,270...35,673,022

G

NCK associated protein 1 like

CTD Direct Evidence: marker/mechanism

NCBI chr12:54,497,752...54,548,243
Ensembl chr12:54,497,752...54,548,243

G

nuclear receptor corepressor 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,612

G

N-myc downstream regulated 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022

G

NDRG family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:21,016,763...21,070,872
Ensembl chr14:21,016,763...21,070,872

G

nectin cell adhesion molecule 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223

G

NIMA related kinase 6

CTD Direct Evidence: marker/mechanism

NCBI chr 9:124,257,606...124,353,307
Ensembl chr 9:124,257,606...124,353,307

G

NFE2 like bZIP transcription factor 2

CTD Direct Evidence: therapeutic

NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756

G

NFKB inhibitor alpha

CTD Direct Evidence: marker/mechanism

NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749

G

NFKB inhibitor epsilon

CTD Direct Evidence: marker/mechanism

NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788

G

NFKB inhibitor zeta

CTD Direct Evidence: marker/mechanism

NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022

G

NHS like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:32,741,830...32,774,970
Ensembl chr 1:32,741,830...32,774,970

G

nidogen 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:235,975,830...236,065,090
Ensembl chr 1:235,975,830...236,065,109

G

nidogen 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:52,004,809...52,069,059
Ensembl chr14:52,004,809...52,069,059

G

NIPA like domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:98,189,826...98,294,235
Ensembl chr 8:98,189,826...98,294,393

G

NLR family CARD domain containing 5

CTD Direct Evidence: marker/mechanism

NCBI chr16:56,989,557...57,083,520
Ensembl chr16:56,989,485...57,083,531

G

N-myc and STAT interactor

CTD Direct Evidence: marker/mechanism

NCBI chr 2:151,270,470...151,289,668
Ensembl chr 2:151,270,470...151,289,894

G

nocturnin

CTD Direct Evidence: marker/mechanism

NCBI chr 4:139,015,781...139,045,939
Ensembl chr 4:139,015,781...139,045,939

G

nitric oxide synthase 2

mRNA:increased expression:heart
mRNA:increased expression:aorta
CTD Direct Evidence: therapeutic

CTD
RGD

PMID:18380797 PMID:10784593 PMID:10353629

RGD:2325265, RGD:2325278

NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529

G

nitric oxide synthase 3

protein:decreased expression:spleen
protein:decreased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:18555214 PMID:17481668 PMID:17918268

RGD:2292140, RGD:2292126

NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588

G

NADPH oxidase 4

CTD Direct Evidence: marker/mechanism

NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187

G

neuronal PAS domain protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:100,818,723...100,996,829
Ensembl chr 2:100,820,139...100,996,829

G

neural proliferation, differentiation and control 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:137,039,463...137,046,177
Ensembl chr 9:137,039,463...137,046,179

G

N-ribosyldihydronicotinamide:quinone dehydrogenase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755

G

nuclear receptor subfamily 0 group B member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975

G

nuclear receptor subfamily 1 group H member 4

treatment

associated with portal hypertension;mRNA;decreased expression;liver (rat)
mRNA:altered expression:liver (rat)

RGD

PMID:27993716 PMID:24259407 PMID:15980055

RGD:14701034, RGD:15045598, RGD:1625201

NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414

G

neuronal regeneration related protein

CTD Direct Evidence: marker/mechanism

NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464

G

neuregulin 1

CTD Direct Evidence: marker/mechanism

NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666

G

negative regulator of reactive oxygen species

CTD Direct Evidence: marker/mechanism

NCBI chr 3:196,639,694...196,662,004
Ensembl chr 3:196,639,694...196,662,004

G

NMDA receptor synaptonuclear signaling and neuronal migration factor

CTD Direct Evidence: marker/mechanism

NCBI chr 9:137,447,570...137,459,334
Ensembl chr 9:137,447,570...137,459,334

G

5'-nucleotidase ecto

CTD Direct Evidence: marker/mechanism

NCBI chr 6:85,450,083...85,495,784
Ensembl chr 6:85,449,584...85,495,791

G

nudix hydrolase 16

CTD Direct Evidence: marker/mechanism

NCBI chr 3:131,381,671...131,388,830
Ensembl chr 3:131,381,671...131,388,830

G

nuclear protein 1, transcriptional regulator

CTD Direct Evidence: marker/mechanism

NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008

G

ornithine aminotransferase

CTD Direct Evidence: marker/mechanism

NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976

G

8-oxoguanine DNA glycosylase

treatment

RGD

NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219

G

olfactomedin like 2B

CTD Direct Evidence: marker/mechanism

NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869

G

olfactomedin like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:113,979,474...113,982,253
Ensembl chr 1:113,979,391...114,035,572

G

olfactory receptor family 51 subfamily E member 2

CTD Direct Evidence: marker/mechanism

NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854

G

oxidative stress induced growth inhibitor 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332

G

oncostatin M

CTD Direct Evidence: therapeutic

NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851

G

ornithine transcarbamylase

protein:decreased activity:liver (rat)
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:7865721

NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,327,598...38,422,908

G

OTU deubiquitinase, ubiquitin aldehyde binding 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:94,026,340...94,048,930
Ensembl chr14:94,026,340...94,048,930

G

OTU deubiquitinase with linear linkage specificity like

CTD Direct Evidence: marker/mechanism

NCBI chr 5:14,581,792...14,616,180
Ensembl chr 5:14,581,792...14,616,180

G

palmdelphin

CTD Direct Evidence: marker/mechanism

NCBI chr 1:99,646,113...99,694,535
Ensembl chr 1:99,646,113...99,694,541

G

peptidase domain containing associated with muscle regeneration 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:35,431,827...35,530,300
Ensembl chr11:35,431,823...35,530,300

G

progestin and adipoQ receptor family member 9

CTD Direct Evidence: marker/mechanism

NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,963,674

G

pyruvate carboxylase

CTD Direct Evidence: marker/mechanism

NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386

G

phosphoenolpyruvate carboxykinase 1

CTD Direct Evidence: marker/mechanism

NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121

G

phosphoenolpyruvate carboxykinase 2, mitochondrial

CTD Direct Evidence: marker/mechanism

NCBI chr14:24,094,171...24,104,125
Ensembl chr14:24,094,053...24,110,598

G

platelet derived growth factor subunit A

CTD Direct Evidence: marker/mechanism

NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296

G

platelet derived growth factor receptor alpha

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:17382907

NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245

G

platelet derived growth factor receptor beta

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15623374 PMID:18466260 PMID:15077122 PMID:18466260

RGD:2292206, RGD:10449503

NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872

G

pyridoxal kinase

protein:decreased expression:brain

RGD

NCBI chr21:43,737,000...43,738,097
Ensembl chr21:43,719,094...43,762,307

G

PDZ domain containing ring finger 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:73,382,431...73,624,941
Ensembl chr 3:73,382,431...73,624,941

G

proliferation and apoptosis adaptor protein 15

CTD Direct Evidence: marker/mechanism

NCBI chr 1:160,205,384...160,215,372
Ensembl chr 1:160,205,380...160,215,376

G

phosphofructokinase, platelet

CTD Direct Evidence: marker/mechanism

NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718

G

profilin 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061

G

placental growth factor

disease_progression

RGD

PMID:17935226 PMID:21520176

RGD:1643338, RGD:6483607

NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626

G

polycystin 2, transient receptor potential cation channel

CTD Direct Evidence: marker/mechanism

NCBI chr 4:88,007,635...88,077,777
Ensembl chr 4:88,007,635...88,077,777

G

pyruvate kinase L/R

CTD Direct Evidence: marker/mechanism

NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438

G

phospholipase A2 group XIIA

CTD Direct Evidence: marker/mechanism

NCBI chr 4:109,709,989...109,730,070
Ensembl chr 4:109,709,989...109,730,070

G

phospholipase A2 group IVA

protein:increased activity:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:17459512

NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981

G

placenta associated 8

CTD Direct Evidence: marker/mechanism

NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,059,493...83,137,075

G

plasminogen activator, tissue type

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:20035854

NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709

G

plasminogen activator, urokinase

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:20035854 PMID:16958060 PMID:23018346

RGD:6484134, RGD:2317516, RGD:7241553

NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496

G

phospholipase D family member 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761

G

pleckstrin

CTD Direct Evidence: marker/mechanism

NCBI chr 2:68,365,282...68,397,453
Ensembl chr 2:68,365,282...68,397,453

G

pleckstrin homology domain containing B1

CTD Direct Evidence: marker/mechanism

NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819

G

pleckstrin homology, MyTH4 and FERM domain containing H1

CTD Direct Evidence: marker/mechanism

NCBI chr14:67,533,290...67,589,612
Ensembl chr14:67,533,290...67,589,612

G

plasminogen

CTD Direct Evidence: therapeutic

NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097

G

perilipin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290

G

perilipin 3

CTD Direct Evidence: marker/mechanism

NCBI chr19:4,838,341...4,867,667
Ensembl chr19:4,838,341...4,867,694

G

procollagen-lysine,2-oxoglutarate 5-dioxygenase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:146,069,440...146,161,184
Ensembl chr 3:146,035,139...146,163,725

G

phospholipid phosphatase 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:281,043...291,403
Ensembl chr19:281,040...291,403

G

phospholipid scramblase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856

G

phospholipid scramblase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:146,391,420...146,495,991
Ensembl chr 3:146,391,421...146,495,991

G

phospholipid transfer protein

CTD Direct Evidence: marker/mechanism

NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,155

G

prostate transmembrane protein, androgen induced 1

CTD Direct Evidence: marker/mechanism

NCBI chr20:57,648,396...57,711,472
Ensembl chr20:57,648,392...57,711,536

G

proopiomelanocortin

CTD Direct Evidence: therapeutic

PMID:16508911 PMID:16511523

NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903

G

peroxisome proliferator activated receptor gamma

treatment

RGD

PMID:18594976 PMID:22529699

RGD:2301874, RGD:8553190

NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356

G

protein phosphatase 1 regulatory subunit 18

CTD Direct Evidence: marker/mechanism

NCBI chr 6:30,676,389...30,688,391
Ensembl chr 6:30,676,389...30,687,895

G

protein phosphatase 1 regulatory subunit 3B

CTD Direct Evidence: marker/mechanism

NCBI chr 8:9,136,255...9,151,539
Ensembl chr 8:9,136,255...9,151,574

G

protein phosphatase 1 regulatory subunit 3C

CTD Direct Evidence: marker/mechanism

NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071

G

PRA1 domain family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr X:49,071,161...49,074,002
Ensembl chr X:49,071,161...49,074,002

G

protein kinase C beta

CTD Direct Evidence: marker/mechanism

NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611

G

protein kinase C delta

CTD Direct Evidence: marker/mechanism

NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717

G

parkin RBR E3 ubiquitin protein ligase

treatment

RGD

NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775

G

prolactin receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487

G

prion protein (Kanno blood group)

CTD Direct Evidence: marker/mechanism

NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590

G

protein C receptor

CTD Direct Evidence: marker/mechanism

NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240

G

proline dehydrogenase 1

CTD Direct Evidence: marker/mechanism

NCBI chr22:18,912,781...18,936,553
Ensembl chr22:18,912,777...18,936,553

G

proline dehydrogenase 2

CTD Direct Evidence: marker/mechanism

NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,988...35,813,299

G

protein S

mRNA, protein:decreased expression:liver, plasma

RGD

NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,051...93,980,003

G

proline rich 13

CTD Direct Evidence: marker/mechanism

NCBI chr12:53,441,734...53,446,638
Ensembl chr12:53,441,678...53,446,645

G

phosphoribosyl transferase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:24,848,614...24,952,606
Ensembl chr10:24,848,614...24,952,606

G

protogenin

CTD Direct Evidence: marker/mechanism

NCBI chr15:55,611,544...55,743,152
Ensembl chr15:55,611,544...55,743,152

G

prune homolog 2 with BCH domain

CTD Direct Evidence: marker/mechanism

NCBI chr 9:76,611,376...76,906,114
Ensembl chr 9:76,611,376...76,906,114

G

proteasome 20S subunit beta 10

CTD Direct Evidence: marker/mechanism

NCBI chr16:67,934,506...67,936,850
Ensembl chr16:67,934,506...67,936,864

G

proteasome 20S subunit beta 8

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,840,717...32,844,679
Ensembl chr 6:32,840,717...32,844,679

G

proteasome 20S subunit beta 9

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,860,734

G

proteasome activator subunit 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:24,143,365...24,146,610
Ensembl chr14:24,143,362...24,147,570

G

proline-serine-threonine phosphatase interacting protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:76,994,680...77,037,475
Ensembl chr15:76,993,359...77,037,475

G

platelet activating factor receptor

CTD Direct Evidence: marker/mechanism

NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936

G

phosphotriesterase related

CTD Direct Evidence: marker/mechanism

NCBI chr10:16,437,010...16,519,020
Ensembl chr10:16,436,943...16,513,745

G

prostaglandin E receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,329,822

G

prostaglandin-endoperoxide synthase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703

G

prostaglandin-endoperoxide synthase 2

CTD Direct Evidence: marker/mechanism

PMID:17565644 PMID:18555214

NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922

G

protein tyrosine kinase 2

mRNA, protein:increased expression:liver

RGD

NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216

G

pleiotrophin

CTD Direct Evidence: marker/mechanism

NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774

G

protein tyrosine phosphatase non-receptor type 1

CTD Direct Evidence: marker/mechanism

NCBI chr20:50,510,383...50,585,241
Ensembl chr20:50,510,321...50,585,241

G

protein tyrosine phosphatase non-receptor type 18

CTD Direct Evidence: marker/mechanism

NCBI chr 2:130,356,056...130,375,405
Ensembl chr 2:130,356,045...130,375,405

G

protein tyrosine phosphatase receptor type C

CTD Direct Evidence: marker/mechanism

NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,759,342

G

protein tyrosine phosphatase receptor type D

CTD Direct Evidence: marker/mechanism

NCBI chr 9:8,314,246...10,613,002
Ensembl chr 9:8,314,246...10,613,002

G

protein tyrosine phosphatase receptor type O

CTD Direct Evidence: marker/mechanism

NCBI chr12:15,322,508...15,598,331
Ensembl chr12:15,322,257...15,602,175

G

peptidyl-tRNA hydrolase 1 homolog

CTD Direct Evidence: marker/mechanism

NCBI chr 9:127,694,150...127,715,676
Ensembl chr 9:127,690,348...127,724,873

G

peptidyl-tRNA hydrolase domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:24,789,728...24,793,391
Ensembl chr 2:24,789,728...24,793,391

G

peroxidasin

CTD Direct Evidence: marker/mechanism

NCBI chr 2:1,631,887...1,744,901
Ensembl chr 2:1,631,887...1,744,852

G

PYD and CARD domain containing

CTD Direct Evidence: marker/mechanism

NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450

G

pyrroline-5-carboxylate reductase 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:81,932,391...81,937,300
Ensembl chr17:81,932,384...81,942,412

G

R3H domain containing 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:57,253,764...57,431,141
Ensembl chr12:57,253,762...57,431,043

G

RAB30, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr11:82,973,133...83,071,897
Ensembl chr11:82,973,133...83,071,923

G

RAB31, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551

G

RAB32, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr 6:146,543,833...146,554,953
Ensembl chr 6:146,543,833...146,554,953

G

RAB40B, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr17:82,654,973...82,698,698
Ensembl chr17:82,654,973...82,698,698

G

RAB8B, member RAS oncogene family

CTD Direct Evidence: marker/mechanism

NCBI chr15:63,189,606...63,267,776
Ensembl chr15:63,189,560...63,267,776

G

RAB GTPase activating protein 1 like

CTD Direct Evidence: marker/mechanism

NCBI chr 1:174,159,520...174,995,308
Ensembl chr 1:174,159,410...174,995,308

G

Rac family small GTPase 2

CTD Direct Evidence: marker/mechanism

NCBI chr22:37,225,270...37,244,269
Ensembl chr22:37,225,270...37,259,594

G

receptor activity modifying protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:237,858,880...237,912,106
Ensembl chr 2:237,858,893...237,912,106

G

receptor activity modifying protein 2

RGD

NCBI chr17:42,761,227...42,763,041
Ensembl chr17:42,758,447...42,763,041

G

retinoic acid receptor responder 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:158,696,892...158,732,457
Ensembl chr 3:158,696,892...158,732,489

G

Ras association domain family member 4

CTD Direct Evidence: marker/mechanism

NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891

G

RB transcriptional corepressor like 2

CTD Direct Evidence: marker/mechanism

NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648

G

RNA binding motif protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,449...48,581,162

G

retinol binding protein 4

mRNA:increased expression:liver (rat)

RGD

NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744

G

reticulocalbin 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:32,091,074...32,105,722
Ensembl chr11:32,091,074...32,105,722

G

reticulocalbin 2

CTD Direct Evidence: marker/mechanism

NCBI chr15:76,931,749...76,954,393
Ensembl chr15:76,931,738...76,954,393

G

RCSD domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:167,630,232...167,708,696
Ensembl chr 1:167,630,093...167,708,696

G

retinol dehydrogenase 10

CTD Direct Evidence: marker/mechanism

NCBI chr 8:73,294,602...73,325,281
Ensembl chr 8:73,294,602...73,325,281

G

retinol dehydrogenase 13

CTD Direct Evidence: marker/mechanism

NCBI chr19:55,039,103...55,069,520
Ensembl chr19:55,039,108...55,071,291

G

reversion inducing cysteine rich protein with kazal motifs

CTD Direct Evidence: marker/mechanism

NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455

G

receptor accessory protein 5

CTD Direct Evidence: marker/mechanism

NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289

G

RELA proto-oncogene, NF-kB subunit

CTD Direct Evidence: marker/mechanism

NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090

G

RELT like 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:37,586,304...37,686,376
Ensembl chr 4:37,590,800...37,686,376

G

reelin

mRNA, protein:increased expression:liver, plasma (rat)

RGD

NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658

G

regucalcin

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314

G

regulator of G protein signaling 10

CTD Direct Evidence: marker/mechanism

NCBI chr10:119,499,817...119,542,719
Ensembl chr10:119,499,817...119,542,719

G

regulator of G protein signaling 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275

G

regulator of G protein signaling 3

CTD Direct Evidence: marker/mechanism

NCBI chr 9:113,444,730...113,597,738
Ensembl chr 9:113,444,731...113,597,743

G

regulator of G protein signaling 5

CTD Direct Evidence: marker/mechanism

NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791

G

ras homolog family member A

mRNA, protein:increased expression:liver

RGD

NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998

G

ras homolog family member Q

CTD Direct Evidence: marker/mechanism

NCBI chr 2:46,542,490...46,584,688
Ensembl chr 2:46,541,806...46,584,688

G

reactive intermediate imine deaminase A homolog

treatment

RGD

NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171

G

Ras like without CAAX 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:155,897,808...155,911,349
Ensembl chr 1:155,897,808...155,911,404

G

regulator of microtubule dynamics 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:37,920,901...38,067,138
Ensembl chr 2:37,923,187...38,067,142

G

required for meiotic nuclear division 5 homolog B

CTD Direct Evidence: marker/mechanism

NCBI chr 5:178,131,014...178,150,568
Ensembl chr 5:178,130,996...178,150,568

G

ribonuclease A family member 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:20,684,560...20,701,216
Ensembl chr14:20,684,560...20,701,216

G

ribonuclease L

CTD Direct Evidence: marker/mechanism

NCBI chr 1:182,573,634...182,589,256
Ensembl chr 1:182,573,634...182,589,256

G

ring finger protein 39

CTD Direct Evidence: marker/mechanism

NCBI chr 6:30,070,270...30,075,769
Ensembl chr 6:30,070,266...30,075,849

G

roundabout guidance receptor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964

G

rabphilin 3A like (without C2 domains)

CTD Direct Evidence: marker/mechanism

NCBI chr17:212,389...352,807
Ensembl chr17:212,389...386,254

G

arginine and serine rich protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:25,242,249...25,338,254
Ensembl chr 1:25,242,249...25,338,213

G

reticulon 4

CTD Direct Evidence: marker/mechanism

NCBI chr 2:54,972,189...55,137,831
Ensembl chr 2:54,972,187...55,112,621

G

receptor transporter protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr 3:46,497,976...46,500,950
Ensembl chr 3:46,494,611...46,500,950

G

retinoid X receptor alpha

RGD

NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585

G

S100 calcium binding protein A10

CTD Direct Evidence: marker/mechanism

NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859

G

S100 calcium binding protein A11

CTD Direct Evidence: marker/mechanism

NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907

G

S100 calcium binding protein A6

CTD Direct Evidence: marker/mechanism

NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244

G

S100 calcium binding protein A9

CTD Direct Evidence: marker/mechanism

NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023

G

sphingosine-1-phosphate receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:101,236,899...101,242,313
Ensembl chr 1:101,236,865...101,243,713

G

sterile alpha motif domain containing 11

CTD Direct Evidence: marker/mechanism

NCBI chr 1:923,923...944,574
Ensembl chr 1:923,923...944,575

G

SAM and SH3 domain containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr X:129,779,949...129,795,201
Ensembl chr X:129,779,949...129,795,201

G

stearoyl-CoA desaturase

CTD Direct Evidence: marker/mechanism

NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826

G

short chain dehydrogenase/reductase family 42E, member 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:81,988,855...82,011,470
Ensembl chr16:81,988,855...82,011,481

G

serine dehydratase

CTD Direct Evidence: marker/mechanism

NCBI chr12:113,392,445...113,403,887
Ensembl chr12:113,392,445...113,426,301

G

selenoprotein M

CTD Direct Evidence: marker/mechanism

NCBI chr22:31,104,777...31,107,568
Ensembl chr22:31,104,772...31,120,069

G

selenoprotein P

CTD Direct Evidence: marker/mechanism

NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392

G

selenoprotein W

CTD Direct Evidence: marker/mechanism

NCBI chr19:47,778,703...47,784,682
Ensembl chr19:47,778,677...47,784,686

G

selectin P

protein:increased expression:bone marrow

RGD

NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193

G

semaphorin 6D

CTD Direct Evidence: marker/mechanism

NCBI chr15:47,184,089...47,774,228
Ensembl chr15:47,184,101...47,774,228

G

SUMO specific peptidase 2

CTD Direct Evidence: therapeutic

NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551

G

serpin family A member 4

CTD Direct Evidence: marker/mechanism

NCBI chr14:94,561,442...94,569,906
Ensembl chr14:94,561,442...94,569,913

G

serpin family A member 6

CTD Direct Evidence: marker/mechanism

NCBI chr14:94,304,248...94,323,336
Ensembl chr14:94,304,248...94,323,389

G

serpin family A member 7

CTD Direct Evidence: marker/mechanism

NCBI chr X:106,032,435...106,038,727
Ensembl chr X:106,032,435...106,038,727

G

serpin family B member 9

CTD Direct Evidence: marker/mechanism

NCBI chr 6:2,887,270...2,903,309
Ensembl chr 6:2,887,173...2,903,309

G

serpin family C member 1

treatment

associated with Inflammatory Bowel Diseases

RGD

NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327

G

serpin family H member 1

CTD Direct Evidence: marker/mechanism

PMID:18376398 PMID:25380136

NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783

G

seizure related 6 homolog

CTD Direct Evidence: marker/mechanism

NCBI chr17:28,954,905...29,006,440
Ensembl chr17:28,954,901...29,006,440

G

sarcoglycan beta

CTD Direct Evidence: marker/mechanism

NCBI chr 4:52,020,706...52,038,299
Ensembl chr 4:52,020,706...52,038,299

G

serum/glucocorticoid regulated kinase 2

CTD Direct Evidence: marker/mechanism

NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237

G

SH3 domain binding glutamate rich protein like 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:26,280,086...26,281,522
Ensembl chr 1:26,280,086...26,281,522

G

SHC binding and spindle associated 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:46,578,591...46,621,379
Ensembl chr16:46,578,591...46,621,379

G

shisa family member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 4:42,397,488...42,402,487
Ensembl chr 4:42,397,488...42,402,487

G

sialic acid binding Ig like lectin 5

CTD Direct Evidence: marker/mechanism

NCBI chr19:51,610,960...51,630,401
Ensembl chr19:51,630,101...51,645,545
Ensembl chr19:51,630,101...51,645,545

G

sirtuin 1

CTD Direct Evidence: therapeutic

NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390

G

src kinase associated phosphoprotein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:26,654,770...26,864,590
Ensembl chr 7:26,667,068...26,995,239

G

SKI like proto-oncogene

RGD

NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835

G

Src like adaptor

CTD Direct Evidence: marker/mechanism

NCBI chr 8:133,036,728...133,102,602
Ensembl chr 8:133,036,728...133,102,912

G

SLAM family member 9

CTD Direct Evidence: marker/mechanism

NCBI chr 1:159,951,492...159,983,984
Ensembl chr 1:159,951,492...159,954,237

G

solute carrier family 10 member 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241

G

solute carrier family 12 member 3

protein:altered expression:kidney (rat)

RGD

NCBI chr16:56,865,207...56,915,850
Ensembl chr16:56,865,207...56,915,850

G

solute carrier family 15 member 3

CTD Direct Evidence: marker/mechanism

NCBI chr11:60,937,084...60,952,176
Ensembl chr11:60,937,060...60,952,653

G

solute carrier family 17 member 1

CTD Direct Evidence: marker/mechanism

PMID:17072980 PMID:25380136

NCBI chr 6:25,723,743...25,832,052
Ensembl chr 6:25,782,915...25,832,052

G

solute carrier family 17 member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:25,912,754...25,930,691
Ensembl chr 6:25,912,754...25,930,691

G

solute carrier family 19 member 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:169,463,909...169,485,970
Ensembl chr 1:169,463,909...169,485,944

G

solute carrier family 20 member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825

G

solute carrier family 22 member 23

CTD Direct Evidence: marker/mechanism

NCBI chr 6:3,268,973...3,457,050
Ensembl chr 6:3,268,962...3,457,050

G

solute carrier family 22 member 25

CTD Direct Evidence: marker/mechanism

NCBI chr11:63,158,437...63,243,599
Ensembl chr11:63,158,437...63,243,599

G

solute carrier family 22 member 8

CTD Direct Evidence: marker/mechanism

NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841

G

solute carrier family 23 member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:139,367,196...139,385,676
Ensembl chr 5:139,367,196...139,384,553

G

solute carrier family 25 member 13

CTD Direct Evidence: marker/mechanism

NCBI chr 7:96,120,220...96,322,098
Ensembl chr 7:96,120,220...96,322,147

G

solute carrier family 25 member 24

CTD Direct Evidence: marker/mechanism

NCBI chr 1:108,134,043...108,200,343
Ensembl chr 1:108,134,043...108,200,849

G

solute carrier family 25 member 30

CTD Direct Evidence: marker/mechanism

NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455

G

solute carrier family 25 member 4

CTD Direct Evidence: marker/mechanism

NCBI chr 4:185,143,266...185,150,382
Ensembl chr 4:185,143,266...185,150,382

G

solute carrier family 37 member 4

CTD Direct Evidence: marker/mechanism

NCBI chr11:119,024,112...119,030,877
Ensembl chr11:119,023,751...119,030,906

G

solute carrier family 39 member 6

CTD Direct Evidence: marker/mechanism

NCBI chr18:36,108,531...36,129,340
Ensembl chr18:36,108,531...36,129,385

G

solute carrier family 39 member 8

CTD Direct Evidence: marker/mechanism

NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258

G

solute carrier family 43 member 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:1,569,254...1,630,088
Ensembl chr17:1,569,268...1,628,886

G

solute carrier family 44 member 2 (CTL2 blood group)

CTD Direct Evidence: marker/mechanism

NCBI chr19:10,602,455...10,644,557
Ensembl chr19:10,602,457...10,644,557

G

solute carrier family 46 member 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:28,394,642...28,406,592
Ensembl chr17:28,394,642...28,407,197

G

solute carrier family 4 member 4

CTD Direct Evidence: marker/mechanism

NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087

G

solute carrier family 66 member 3

CTD Direct Evidence: marker/mechanism

NCBI chr 2:11,155,467...11,178,856
Ensembl chr 2:11,155,198...11,178,870

G

solute carrier family 7 member 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688

G

SMAD family member 1

RGD

NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176

G

SMAD family member 2

CTD Direct Evidence: marker/mechanism

NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146

G

SMAD family member 3

treatment

RGD

PMID:30346985 PMID:25691930

RGD:151665755, RGD:401976485

NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173

G

SMAD family member 4

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16570350 PMID:19824107

NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045

G

SWI/SNF related BAF chromatin remodeling complex subunit C1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:47,585,269...47,781,893
Ensembl chr 3:47,585,269...47,782,106

G

structural maintenance of chromosomes 2

CTD Direct Evidence: marker/mechanism

NCBI chr 9:104,088,263...104,141,419
Ensembl chr 9:104,094,260...104,141,419

G

structural maintenance of chromosomes 5

CTD Direct Evidence: marker/mechanism

NCBI chr 9:70,258,978...70,354,873
Ensembl chr 9:70,258,978...70,354,873

G

SPARC related modular calcium binding 1

CTD Direct Evidence: marker/mechanism

NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366

G

SPARC related modular calcium binding 2

CTD Direct Evidence: marker/mechanism

NCBI chr 6:168,441,184...168,667,992
Ensembl chr 6:168,441,151...168,673,445

G

synaptosome associated protein 23

CTD Direct Evidence: marker/mechanism

NCBI chr15:42,491,129...42,533,058
Ensembl chr15:42,491,233...42,545,356

G

synaptosome associated protein 29

CTD Direct Evidence: marker/mechanism

NCBI chr22:20,859,007...20,891,214
Ensembl chr22:20,859,007...20,891,214

G

sorting nexin 7

CTD Direct Evidence: marker/mechanism

NCBI chr 1:98,661,319...98,760,500
Ensembl chr 1:98,661,701...98,760,500

G

sterol O-acyltransferase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,714...179,358,680

G

suppressor of cytokine signaling 1

CTD Direct Evidence: marker/mechanism

NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204

G

suppressor of cytokine signaling 2

CTD Direct Evidence: marker/mechanism

NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487

G

SRY-box transcription factor 4

CTD Direct Evidence: marker/mechanism

NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619

G

SP140 nuclear body protein

CTD Direct Evidence: marker/mechanism

NCBI chr 2:230,186,151...230,316,571
Ensembl chr 2:230,203,110...230,313,215

G

secreted protein acidic and cysteine rich

mRNA:increased expression:liver, fat cell
CTD Direct Evidence: marker/mechanism|therapeutic

CTD
RGD

PMID:18615449 PMID:25380136 PMID:18615449 PMID:8786698

RGD:2300030, RGD:2300071

NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975

G

spindlin family member 2A

CTD Direct Evidence: marker/mechanism

NCBI chr X:57,134,265...57,147,180
Ensembl chr X:57,134,530...57,137,523

G

secreted phosphoprotein 1

RGD

NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532

G

splA/ryanodine receptor domain and SOCS box containing 4

CTD Direct Evidence: marker/mechanism

NCBI chr 3:141,051,347...141,148,611
Ensembl chr 3:141,051,347...141,148,611

G

spectrin alpha, non-erythrocytic 1

CTD Direct Evidence: marker/mechanism

NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662

G

steroid 5 alpha-reductase 1

CTD Direct Evidence: marker/mechanism

NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539

G

sterol regulatory element binding transcription factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002

G

serglycin

CTD Direct Evidence: marker/mechanism

NCBI chr10:69,087,603...69,104,811
Ensembl chr10:69,088,103...69,104,811

G

sorcin

CTD Direct Evidence: marker/mechanism

NCBI chr 7:88,205,115...88,226,976
Ensembl chr 7:88,205,115...88,226,993

G

serine racemase

CTD Direct Evidence: marker/mechanism

NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260

G

ST14 transmembrane serine protease matriptase

CTD Direct Evidence: marker/mechanism

NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362

G

SH3 and cysteine rich domain 3

CTD Direct Evidence: marker/mechanism

NCBI chr12:57,243,458...57,251,187
Ensembl chr12:57,243,453...57,251,188

G

StAR related lipid transfer domain containing 13

CTD Direct Evidence: marker/mechanism

NCBI chr13:33,103,137...33,676,794
Ensembl chr13:33,103,137...33,350,630

G

signal transducer and activator of transcription 3

treatment

RGD

NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568

G

signal transducer and activator of transcription 5A

treatment

RGD

NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943

G

staufen double-stranded RNA binding protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:73,420,369...73,747,480
Ensembl chr 8:73,420,369...73,747,708

G

STEAP4 metalloreductase

CTD Direct Evidence: marker/mechanism

NCBI chr 7:88,270,892...88,306,894
Ensembl chr 7:88,270,892...88,306,894

G

serine/threonine kinase 10

CTD Direct Evidence: marker/mechanism

NCBI chr 5:172,042,079...172,188,224
Ensembl chr 5:172,042,079...172,188,224

G

sulfotransferase family 1E member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145

G

sulfotransferase family 2A member 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315

G

synergin gamma

CTD Direct Evidence: marker/mechanism

NCBI chr17:37,514,807...37,609,418
Ensembl chr17:37,514,807...37,609,472

G

transgelin 2

CTD Direct Evidence: marker/mechanism

NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507

G

transporter 2, ATP binding cassette subfamily B member

CTD Direct Evidence: marker/mechanism

NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739

G

Tax1 binding protein 3

CTD Direct Evidence: marker/mechanism

NCBI chr17:3,662,895...3,668,578
Ensembl chr17:3,662,895...3,668,679

G

TBC1 domain family member 9

CTD Direct Evidence: marker/mechanism

NCBI chr 4:140,620,782...140,756,385
Ensembl chr 4:140,620,782...140,756,385

G

transcription factor 20

CTD Direct Evidence: marker/mechanism

NCBI chr22:42,160,013...42,343,537
Ensembl chr22:42,160,013...42,343,616

G

transcription factor 4

CTD Direct Evidence: marker/mechanism

NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787

G

telomerase reverse transcriptase

protein:increased expression, increased localization:nucleus

RGD

NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068

G

testin LIM domain protein

CTD Direct Evidence: marker/mechanism

NCBI chr 7:116,210,539...116,258,783
Ensembl chr 7:116,210,506...116,258,783

G

transferrin

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:15650968 PMID:22464783

NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641

G

transcription factor EC

CTD Direct Evidence: marker/mechanism

NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896

G

tissue factor pathway inhibitor 2

CTD Direct Evidence: marker/mechanism

NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753

G

transforming growth factor beta 1

treatment
onset

protein:increased expression:liver
CTD Direct Evidence: marker/mechanism|therapeutic
associated with Chemical and Drug Induced Liver Injury
associated with extrahepatic cholestasis
mRNA:increased expression:liver (mouse)

CTD
RGD

PMID:12586293 PMID:15772939 PMID:16579972 PMID:26806094 PMID:27605418 More...

RGD:1601595, RGD:14985231, RGD:14985232, RGD:14985234, RGD:14995475, RGD:39939037

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

transforming growth factor beta 3

CTD Direct Evidence: marker/mechanism

NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011

G

transforming growth factor beta receptor 1

protein:increased expression:liver

RGD

PMID:16009107 PMID:15723089

RGD:1601595, RGD:2302027

NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192

G

transforming growth factor beta receptor 2

treatment

CTD Direct Evidence: therapeutic

CTD
RGD

PMID:15942678 PMID:16627068 PMID:16627068 PMID:30346985

RGD:1579923, RGD:151665755

NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249

G

tyrosine hydroxylase

mRNA:decreased expression:superior mesenteric artery (rat)

RGD

NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815

G

thrombomodulin

protein:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:21112949

NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672

G

thrombopoietin

mRNA:decreased expression:liver

NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968

G

thymocyte nuclear protein 1

CTD Direct Evidence: marker/mechanism

NCBI chr11:134,248,282...134,253,352
Ensembl chr11:134,248,279...134,253,370

G

TIA1 cytotoxic granule associated RNA binding protein like 1

CTD Direct Evidence: marker/mechanism

NCBI chr10:119,573,465...119,596,964
Ensembl chr10:119,571,802...119,597,029

G

TIMP metallopeptidase inhibitor 1

mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:16507762 PMID:16718785 PMID:16762003 PMID:21163135 PMID:25380136 More...

NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789

G

TIMP metallopeptidase inhibitor 2

CTD Direct Evidence: marker/mechanism

NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387

G

triokinase and FMN cyclase

CTD Direct Evidence: marker/mechanism

NCBI chr11:61,333,228...61,353,426
Ensembl chr11:61,333,220...61,353,295

G

toll like receptor 2

treatment

RGD

PMID:22683883 PMID:27601294

RGD:7241092, RGD:18182936

NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260

G

toll like receptor 3

RGD

NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073

G

toll like receptor 4

treatment

CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:25380136 PMID:22683883 PMID:27601294

RGD:7241092, RGD:18182936

NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735

G

transmembrane 6 superfamily member 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:83,107,645...83,137,408
Ensembl chr15:83,107,572...83,144,854

G

transmembrane BAX inhibitor motif containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:218,274,197...218,292,503
Ensembl chr 2:218,274,197...218,292,586

G

transmembrane protein 106A

CTD Direct Evidence: marker/mechanism

NCBI chr17:43,211,875...43,220,041
Ensembl chr17:43,211,835...43,220,041

G

transmembrane protein 165

CTD Direct Evidence: marker/mechanism

NCBI chr 4:55,395,957...55,453,397
Ensembl chr 4:55,395,957...55,453,397

G

transmembrane protein 178A

CTD Direct Evidence: marker/mechanism

NCBI chr 2:39,665,483...39,735,960
Ensembl chr 2:39,664,982...39,717,963

G

transmembrane protein 184B

CTD Direct Evidence: marker/mechanism

NCBI chr22:38,216,395...38,273,010
Ensembl chr22:38,219,291...38,273,010

G

transmembrane protein 43

CTD Direct Evidence: marker/mechanism

NCBI chr 3:14,125,052...14,143,680
Ensembl chr 3:14,125,015...14,143,680

G

transmembrane protein 65

CTD Direct Evidence: marker/mechanism

NCBI chr 8:124,306,189...124,372,701
Ensembl chr 8:124,306,189...124,372,701

G

thymosin beta 10

CTD Direct Evidence: marker/mechanism

NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671

G

tumor necrosis factor

treatment

CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (mouse)

CTD
RGD

PMID:16085334 PMID:24383550 PMID:28465467

RGD:10450610, RGD:39939037

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

TNF alpha induced protein 8

CTD Direct Evidence: marker/mechanism

NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688

G

TNF receptor superfamily member 12A

CTD Direct Evidence: marker/mechanism

NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383

G

torsin family 4 member A

CTD Direct Evidence: marker/mechanism

NCBI chr 9:137,277,726...137,282,641
Ensembl chr 9:137,277,726...137,282,641

G

tropomyosin 1

CTD Direct Evidence: marker/mechanism

NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915

G

tropomyosin 3

CTD Direct Evidence: marker/mechanism

NCBI chr 1:154,155,308...154,192,100
Ensembl chr 1:154,155,308...154,194,648

G

tropomyosin 4

CTD Direct Evidence: marker/mechanism

NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,005

G

TRAF-type zinc finger domain containing 1

CTD Direct Evidence: marker/mechanism

NCBI chr12:112,125,560...112,153,604
Ensembl chr12:112,125,538...112,153,604

G

trafficking kinesin protein 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:201,377,207...201,451,458
Ensembl chr 2:201,377,207...201,451,500

G

tribbles pseudokinase 3

CTD Direct Evidence: marker/mechanism

NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559

G

tripartite motif containing 24

CTD Direct Evidence: marker/mechanism

NCBI chr 7:138,460,259...138,589,996
Ensembl chr 7:138,460,259...138,589,996

G

tripartite motif containing 59

CTD Direct Evidence: marker/mechanism

NCBI chr 3:160,435,503...160,449,786
Ensembl chr 3:160,432,445...160,485,773

G

transient receptor potential cation channel subfamily V member 1

CTD Direct Evidence: marker/mechanism

NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411

G

TSC22 domain family member 1

CTD Direct Evidence: marker/mechanism

NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147

G

tetraspanin 8

CTD Direct Evidence: marker/mechanism

NCBI chr12:71,125,096...71,157,999
Ensembl chr12:71,125,085...71,441,898

G

translocator protein

CTD Direct Evidence: marker/mechanism

NCBI chr22:43,151,559...43,163,242
Ensembl chr22:43,151,547...43,163,242

G

thiosulfate sulfurtransferase like domain containing 3

CTD Direct Evidence: marker/mechanism

NCBI chr 6:99,521,049...99,587,775
Ensembl chr 6:99,520,976...99,589,899

G

tetratricopeptide repeat domain 36

CTD Direct Evidence: marker/mechanism

NCBI chr11:118,527,474...118,530,993
Ensembl chr11:118,527,472...118,531,197

G

tubulin beta 6 class V

CTD Direct Evidence: marker/mechanism

NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320

G

tumor suppressor candidate 3

CTD Direct Evidence: marker/mechanism

NCBI chr 8:15,417,188...15,852,091
Ensembl chr 8:15,417,215...15,766,649

G

transmembrane immune signaling adaptor TYROBP

CTD Direct Evidence: marker/mechanism

NCBI chr19:35,904,403...35,908,295
Ensembl chr19:35,904,401...35,908,295

G

U2 snRNP associated SURP domain containing

CTD Direct Evidence: marker/mechanism

NCBI chr 3:143,001,570...143,060,725
Ensembl chr 3:142,964,497...143,060,725

G

ubiquitin D

CTD Direct Evidence: marker/mechanism

NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732

G

UDP-glucose ceramide glucosyltransferase

CTD Direct Evidence: marker/mechanism

NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369

G

unc-5 family C-terminal like

CTD Direct Evidence: marker/mechanism

NCBI chr 6:41,026,895...41,039,221
Ensembl chr 6:41,026,895...41,039,221

G

unc-93 homolog B1, TLR signaling regulator

CTD Direct Evidence: marker/mechanism

NCBI chr11:67,991,100...68,004,097
Ensembl chr11:67,991,100...68,004,982

G

vasodilator stimulated phosphoprotein

CTD Direct Evidence: marker/mechanism

NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,989

G

vav guanine nucleotide exchange factor 1

CTD Direct Evidence: marker/mechanism

NCBI chr19:6,772,708...6,857,361
Ensembl chr19:6,772,708...6,857,366

G

vascular endothelial growth factor A

CTD Direct Evidence: marker/mechanism|therapeutic

PMID:18416461 PMID:18458672

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

G

vimentin

CTD Direct Evidence: marker/mechanism
associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat)

CTD
RGD

PMID:25380136 PMID:29323718

NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593

G

vasoactive intestinal peptide receptor 1

CTD Direct Evidence: marker/mechanism

NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573

G

VOPP1 WW domain binding protein

CTD Direct Evidence: marker/mechanism

NCBI chr 7:55,434,964...55,572,502
Ensembl chr 7:55,436,056...55,572,988

G

V-set immunoregulatory receptor

CTD Direct Evidence: marker/mechanism

NCBI chr10:71,747,556...71,773,520
Ensembl chr10:71,747,556...71,773,520

G

von Willebrand factor

protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism

CTD
RGD

PMID:28527913 PMID:7531171

NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770

G

WAP four-disulfide core domain 2

CTD Direct Evidence: marker/mechanism

NCBI chr20:45,469,753...45,481,532
Ensembl chr20:45,469,753...45,481,532

G

WAP four-disulfide core domain 21, pseudogene

CTD Direct Evidence: marker/mechanism

NCBI chr17:60,083,566...60,088,467
Ensembl chr17:60,085,109...60,088,286
Ensembl chr17:60,085,109...60,088,286

G

WAS/WASL interacting protein family member 1

CTD Direct Evidence: marker/mechanism

NCBI chr 2:174,559,574...174,682,913
Ensembl chr 2:174,559,572...174,682,916

G

Wnt ligand secretion mediator

CTD Direct Evidence: marker/mechanism

NCBI chr 1:68,098,459...68,232,546
Ensembl chr 1:68,098,473...68,233,120

G

X-prolyl aminopeptidase 2

CTD Direct Evidence: marker/mechanism

NCBI chr X:129,738,979...129,769,536
Ensembl chr X:129,738,949...129,769,536

G

Y-box binding protein 1

CTD Direct Evidence: therapeutic

NCBI chr 1:42,682,418...42,703,805
Ensembl chr 1:42,682,418...42,703,805

G

yippee like 3

CTD Direct Evidence: marker/mechanism

NCBI chr16:30,092,314...30,096,213
Ensembl chr16:30,092,314...30,096,915

G

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma

CTD Direct Evidence: marker/mechanism

NCBI chr 7:76,326,799...76,358,991
Ensembl chr 7:76,326,799...76,358,991

G

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta

CTD Direct Evidence: marker/mechanism

NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388

G

zinc finger and BTB domain containing 4

CTD Direct Evidence: marker/mechanism

NCBI chr17:7,459,378...7,484,249
Ensembl chr17:7,459,366...7,484,263

G

zinc finger DHHC-type palmitoyltransferase 13

CTD Direct Evidence: marker/mechanism

NCBI chr11:19,117,104...19,176,415
Ensembl chr11:19,117,099...19,176,422

G

zinc finger DHHC-type palmitoyltransferase 2

CTD Direct Evidence: marker/mechanism

NCBI chr 8:17,156,482...17,224,799
Ensembl chr 8:17,156,482...17,224,799

G

zinc finger E-box binding homeobox 2

CTD Direct Evidence: marker/mechanism

NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057

G

ZFP37 zinc finger protein

CTD Direct Evidence: marker/mechanism

NCBI chr 9:113,038,377...113,056,724
Ensembl chr 9:113,038,377...113,056,759

G

zinc finger FYVE-type containing 16

CTD Direct Evidence: marker/mechanism

NCBI chr 5:80,407,610...80,483,379
Ensembl chr 5:80,408,013...80,483,379

G

zinc finger protein 705A

CTD Direct Evidence: marker/mechanism

NCBI chr12:8,157,015...8,180,046
Ensembl chr12:8,157,015...8,188,537

Term paths to the root

Path 1
Term	Annotations
disease	145369
disease of anatomical entity	132557
endocrine system disease	24621
liver disease	4309
liver cirrhosis	1601
Experimental Liver Cirrhosis	911
Path 2
Term	Annotations
disease	145369
disease of anatomical entity	132557
gastrointestinal system disease	21089
hepatobiliary disease	5165
liver disease	4309
liver cirrhosis	1601
Experimental Liver Cirrhosis	911

paths to the root